image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
d13cf3efb50d1060b40d467275bd352b3359f89fe89ac2c0c2c740979310104b.png | simple | <table><tr><td>Line item category</td><td>Uganda per district (US$)</td><td>Kenya per district (US$)</td><td>% Uganda</td><td>% Kenya</td></tr><tr><td>Equipment</td><td>3,947</td><td>4,015</td><td>27.3</td><td>25.9</td></tr><tr><td>Consumables</td><td>502</td><td>91</td><td>3.5</td><td>0.6</td></tr><tr><td> Salaries</t... | <table><tr><td>Line item category</td><td>Uganda per district (US$)</td><td>Kenya per district (US$)</td><td>% Uganda</td><td>% Kenya</td></tr><tr><td>Equipment</td><td>3,947</td><td>4,015</td><td>27.3</td><td>25.9</td></tr><tr><td>Consumables</td><td>502</td><td>91</td><td>3.5</td><td>0.6</td></tr><tr><td>Salaries</td... | <table><tr><td>Room rental</td><td>521</td><td>816</td><td>3.6</td><td>5.3</td></tr><tr><td>Fees</td><td>93</td><td>19</td><td>0.6</td><td>0.1</td></tr><tr><td>Other</td><td>585</td><td>401</td><td>4.1</td><td>2.6</td></tr><tr><td>TOTAL</td><td>14,439</td><td>15,512</td><td>100.0</td><td>100.0</td></tr></table> |
a4f9099064478e79dedbbfc15822886be74600ca7a9425b44932777974866842.png | simple | <table><tr><td>Ref.</td><td>Age</td><td>Sex</td><td>Implementation period</td><td>Admission to hospital</td><td>Location</td><td>Type of plant</td><td>Approach to lesions</td><td>Healing time</td></tr><tr><td>2</td><td>64</td><td>M</td><td>12 h</td><td>Immediately</td><td>Left distal thigh</td><td><i>R. arvensis</i></t... | <table><tr><td>Ref.</td><td>Age</td></tr><tr><td>2</td><td>64</td></tr><tr><td>3</td><td>17</td></tr><tr><td>4</td><td>42</td></tr><tr><td></td><td>40</td></tr><tr><td></td><td>60</td></tr><tr><td></td><td>65</td></tr><tr><td></td><td>48</td></tr><tr><td>5</td><td>52-76</td></tr><tr><td>6</td><td>55</td></tr><tr><td>7<... | <table><tr><td>Sex</td><td>Implementation period</td><td>Admission to hospital</td><td>Location</td><td>Type of plant</td><td>Approach to lesions</td><td>Healing time</td></tr><tr><td>M</td><td>12 h</td><td>Immediately</td><td>Left distal thigh</td><td>R. arvensis</td><td>Debridement, topical nitrofurantoin</td><td>3 w... |
c881098b4cfd4e7528e6218a94227ca3d77d5c5f028bbccacf3e6950c95b90ca.png | complex | <table><tr><td>Baseline characteristics</td><td>Overall no. of patients (%)</td><td>Arm A (%)</td><td>Arm B (%)</td><td>Arm C (%)</td></tr><tr><td>Total</td><td>19</td><td>5</td><td>8</td><td>6</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Median</td><td>60</td><td>51</td><td>57.5</td><... | <table><tr><td>Baseline characteristics</td><td>Overall no. of patients (%)</td><td>Arm A (%)</td><td>Arm B (%)</td><td>Arm C (%)</td></tr><tr><td>To</td><td></td><td>5</td><td></td><td></td></tr></table> | <table><tr><td>tal</td><td>19</td><td></td><td>8</td><td>6</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td>Median</td><td>60</td><td>51</td><td>57.5</td><td>61.5</td></tr><tr><td>Range</td><td>27–86</td><td>27–71</td><td>50–86</td><td>47–77</td></tr><tr><td>Sex</td><td></td><td></td><td></td><... |
bed9b4658b7ed04707d85c291b4f9ef38a687f5c9ef9bdc0bdf47f18042507b5.png | simple | <table><tr><td> Method </td><td> Precision </td><td> Recall </td><td><i>F</i><sub>1</sub></td></tr><tr><td> SVM only </td><td> 0.6 </td><td> 0.12 </td><td> 0.2</td></tr><tr><td> With del+WkNN </td><td> 0.7879 </td><td> 0.26 </td><td> 0.391 </td></tr><tr><td> With add+WkNN </td><td> 0.66 </td><td> 0.33 </td><td> 0.44</t... | <table><tr><td>Method</td><td>Precision</td><td>Recall</td><td>F1</td></tr><tr><td>SVM </td><td>0</td><td>0</td><td></td></tr></table> | <table><tr><td>only</td><td>.6</td><td>.12</td><td>0.2</td></tr><tr><td>With del+WkNN</td><td>0.7879</td><td>0.26</td><td>0.391</td></tr><tr><td>With add+WkNN</td><td>0.66</td><td>0.33</td><td>0.44</td></tr><tr><td>With del+SoftSL</td><td>0.2140</td><td>0.64</td><td>0.3208</td></tr><tr><td>With add+SoftSL</td><td>0.465... |
7a2b0902e50b49f5265e4ca442b394ca98566b7d2adfaea206909150593f763f.png | simple | <table><tr><td></td><td>without hot compress</td><td>with hot compress</td></tr><tr><td>ICG-half-life [min]</td><td>5.88 ± 0.49</td><td>5.35 ± 0.5</td></tr><tr><td>k-value (%/min)</td><td>11.8 ± 1.0</td><td>13.0 ± 1.2</td></tr><tr><td>Room temperature [°C]</td><td>21.2 ± 0.8</td><td>22.1 &... | <table><tr><td></td><td>without hot compress</td><td>with hot compress</td></tr><tr><td>ICG-half-life [min]</td><td>5.88 ± 0.49</td><td>5.35 ± 0.5</td></tr><tr><td>k-value (%/min)</td><td>11.8 ± 1.0</td><td>13.0 ± 1.2</td></tr><tr><td>Room temperature [°C]</td><td>21.2 ± 0.8</td><td>22.1 ± 0.6</td></tr><tr><td>Skin tem... | <table><tr><td></td><td>without hot compress</td><td>with hot compress</td></tr><tr><td>Systolic blood pressure [mmHg]</td><td>132 ± 18</td><td>132 ± 21</td></tr><tr><td>Diastolic blood pressure [mmHg]</td><td>86 ± 11</td><td>87 ± 16</td></tr></table> |
9e49429f41ad0ca1ba8ed983e753d673869da629260617d7691ca9cc77858b96.png | complex | <table><tr><td>Management</td><td>All patients(<i>n</i> = 1,903)</td><td>Age ≥ 65 years(<i>n</i> = 975)</td><td>Age < 65 years(<i>n</i> = 928)</td></tr><tr><td colspan="4">Initial method (%)</td></tr><tr><td> Sedation without paralysis</td><td>682 (36)</td><td>360 (37)</td><td>322 (35)</td></tr><tr><td> Oral w... | <table><tr><td>Management</td><td>All patients(n = 1,903)</td><td>Age ≥ 65 years(n = 975)</td><td>Age < 65 years(n = 928)</td></tr><tr><td colspan="4">Initial method (%)</td></tr><tr><td>Sedation without paralysis</td><td>682 (36)</td><td>360 (37)</td><td>322 (35)</td></tr><tr><td>Oral without medication</td><td>546 (2... | <table><tr><td>Management</td><td>All patients(n = 1,903)</td><td>Age ≥ 65 years(n = 975)</td><td>Age < 65 years(n = 928)</td></tr><tr><td>Other‡</td><td>36 (2)</td><td>13 (1)</td><td>23 (2)</td></tr><tr><td colspan="4">Paralytic (%)</td></tr><tr><td>No paralytics</td><td>1,291 (68)</td><td>689 (71)</td><td>602 (65)</t... |
f6094e208fcc92ef90185c4ff86b49ddd0888142e66c659167bc4b03d5aed85e.png | simple | <table><tr><td>siRNA name</td><td>sequence</td></tr><tr><td>A2-3UTR 1</td><td>5′-UUAAUUCUCUCCGUAGCUCCCCC-3′</td></tr><tr><td>A2-3UTR 2</td><td>5′-UCUUACUGUUCCAUUGGCCCCC-3′</td></tr><tr><td>A2-3UTR 3</td><td>5′-AUUAUCCUUAAGAACCUAGCCCCC-3′</td></tr><tr><td>A2-3UTR 4</td><td>5′-UU... | <table><tr><td>siRNA name</td></tr><tr><td>A2-3UTR 1</td></tr><tr><td>A2-3UTR 2</td></tr><tr><td>A2-3UTR 3</td></tr><tr><td>A2-3UTR 4</td></tr><tr><td>scrambled siRNA</td></tr></table> | <table><tr><td>sequence</td></tr><tr><td>5′-UUAAUUCUCUCCGUAGCUCCCCC-3′</td></tr><tr><td>5′-UCUUACUGUUCCAUUGGCCCCC-3′</td></tr><tr><td>5′-AUUAUCCUUAAGAACCUAGCCCCC-3′</td></tr><tr><td>5′-UUCUUACUGUUCCAUUGGCCCCC-3′</td></tr><tr><td>5′-UAAGCACGAAGCUCAGAGUCCCCC-3′</td></tr></table> |
a9f4f2fcc3be91c40c6b3762e5c483d4f87873b1b85adb125a7797dfcef8a942.png | complex | <table><tr><td></td><td>Number of patients (%)</td><td>Return of spontaneous circulation (<i>n</i>)</td><td><i>P </i>value</td><td colspan="2">Initial survival</td><td colspan="2">Final survival</td></tr><tr><td></td><td></td><td></td><td></td><td><i>n</i></td><td><i>P </i>value</td><td><i>n</i></td><td><i>P </i>value<... | <table><tr><td></td><td>Number of patients (%)</td><td>Return of spontaneous circulation (n)</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td><1 month</td><td>2 (4.5%)</td><td>1</td></tr><tr><td>1–12 months</td><td>9 (20.4%)</td><td>2</td></tr><tr><td>1–8 years</td><td>13 (29.... | <table><tr><td>P value</td><td colspan="2">Initial survival</td><td colspan="2">Final survival</td></tr><tr><td></td><td>n</td><td>P value</td><td>n</td><td>P value</td></tr><tr><td>0.027</td><td></td><td>0.149</td><td></td><td>0.390</td></tr><tr><td></td><td>0</td><td></td><td>0</td><td></td></tr><tr><td></td><td>2</t... |
8e0c23efe880343acd8618f8716ab697e46e7d20bbd3896ce061470495e40c75.png | complex | <table><tr><td>Comorbidity</td><td>Classification by severity</td><td colspan="3">PCs</td></tr><tr><td></td><td></td><td>n</td><td>n (%)</td><td>p</td></tr><tr><td>Heart disease</td><td>surgical or interventional</td><td>19</td><td>5 (26)</td><td>0.26</td></tr><tr><td></td><td>only medication</td><td>31</td><td>13 (42)... | <table><tr><td>Comorbidity</td><td>Classification by severity</td><td colspan="3">PCs</td></tr><tr><td></td><td></td><td>n</td><td>n (%)</td><td>p</td></tr></table> | <table><tr><td>Heart disease</td><td>surgical or interventional</td><td>19</td><td>5 (26)</td><td>0.26</td></tr><tr><td></td><td>only medication</td><td>31</td><td>13 (42)</td><td></td></tr><tr><td>COPD</td><td>stage 3 or 4*</td><td>8</td><td>0 (0)</td><td>0.60</td></tr><tr><td></td><td>stage 1 or 2</td><td>104</td><td... |
5a0a3cb936d404f9ecb27716304b8eb8a3c96fc317c1271f32ffdf20bb75e9fd.png | simple | <table><tr><td>1. Of three influenza reference strains provided to WHO (A/California/7/2009, A/California/4/2009 and A/Texas/5/2009) by NHRC and USAFSAM, the A/California/7/2009 was selected as the seed strain.</td></tr><tr><td>2. Two biosafety-level 3 (BSL-3) laboratories were commissioned in 2009 at NHRC in San Diego... | <table><tr><td>1. Of three influenza reference strains provided to WHO (A/California/7/2009, A/California/4/2009 and A/Texas/5/2009) by NHRC and USAFSAM, the A/California/7/2009 was selected as the seed strain.</td></tr><tr><td>2. Two biosafety-level 3 (BSL-3) laboratories were commissioned in 2009 at NHRC in San Diego... | <table><tr><td>1. Of three influenza reference strains provided to WHO (A/California/7/2009, A/California/4/2009 and A/Texas/5/2009) by NHRC and USAFSAM, the A/California/7/2009 was selected as the seed strain.</td></tr><tr><td>8. NEPMU-2, NAMRU-3, and AFHSC collaboratively supported CENTCOM efforts in establishing in-... |
600c7f4e14ad9424df5c868ec144bf6035a4116c10218204c6f159cccf3d364c.png | simple | <table><tr><td>Protein</td><td>Description</td><td>Other Aliases</td></tr><tr><td>BOD1</td><td>biorientation of chromosomes in cell division 1</td><td>FAM44B</td></tr><tr><td>CENPW</td><td>centromere protein W</td><td>CUG2</td></tr><tr><td>CENPN</td><td>centromere protein N</td><td>CENP-N</td></tr><tr><td>CCNB2</td><td... | <table><tr><td>Protein</td><td>Description</td><td>Other Aliases</td></tr><tr><td>BOD1</td><td>biorientation of chromosomes in cell division 1</td><td>FAM44B</td></tr><tr><td>CENPW</td><td>centromere protein W</td><td>CUG2</td></tr><tr><td>CENPN</td><td>centromere protein N</td><td>CENP-N</td></tr><tr><td>CCNB2</td><td... | <table><tr><td>Protein</td><td>Description</td><td>Other Aliases</td></tr><tr><td>GMNN</td><td>geminin, DNA replication inhibitor</td><td>Gem</td></tr><tr><td>HAUS1</td><td>HAUS augmin-like complex, subunit 1</td><td>CCDC5</td></tr><tr><td>ITGB3BP</td><td>integrin beta 3 binding protein (beta3-endonexin)</td><td>CENPR<... |
23390013446a3cd1fd01283ddc4750855451780939bd2027d5da98a5ac8f87f7.png | simple | <table><tr><td>Tool</td><td>Method</td><td>Symbol</td><td>Ref.</td><td>Time/Gbase</td></tr><tr><td>FragGeneScan</td><td>Hidden Markov Model</td><td>FGS3,FGS5</td><td>[11]</td><td>6 hours</td></tr><tr><td>MetaGeneAnnotator</td><td>Codon usage + start site heuristics</td><td>MGA</td><td>[9]</td><td>15 min</td></tr><tr><t... | <table><tr><td>Tool</td><td>Method</td><td>Symbol</td><td>Ref.</td><td>Time/Gbase</td></tr><tr><td>FragGeneScan</td><td>Hidden Markov Model</td><td>FGS3,FGS5</td><td>[11]</td><td>6 hours</td></tr></table> | <table><tr><td>Tool</td><td>Method</td><td>Symbol</td><td>Ref.</td><td>Time/Gbase</td></tr><tr><td>MetaGeneAnnotator</td><td>Codon usage + start site heuristics</td><td>MGA</td><td>[9]</td><td>15 min</td></tr><tr><td>MetaGeneMark</td><td>Codon usage + gc-content heuristics</td><td>MGM</td><td>[8]</td><td>20 min</td></t... |
43e03ef2516c572053fc56e756338d19a416e84655f7e5b870f6cfecabcb08ad.png | complex | <table><tr><td rowspan="2">Parameters</td><td>AM</td><td>PM</td><td>ABS Diff</td><td>% Error</td><td></td></tr><tr><td>Mean ± SD (max)</td><td>Mean ± SD (max)</td><td>Mean ± SD (max)</td><td>Mean ± SD (max)</td><td><i>P</i> Value</td></tr><tr><td>SS Angle</td><td>38.26 ± 9.16(53.8)</td><td>37.8... | <table><tr><td rowspan="2">Parameters</td><td>AM</td><td>PM</td><td>ABS Diff</td><td>% Error</td><td></td></tr><tr><td>Mean ± SD (max)</td><td>Mean ± SD (max)</td><td>Mean ± SD (max)</td><td>Mean ± SD (max)</td><td>P Value</td></tr></table> | <table><tr><td>SS Angle</td><td>38.26 ± 9.16(53.8)</td><td>37.82 ± 10.15(56.3)</td><td>37.82 ± 10.15(56.3)</td><td>16.17 ± 20.28(99.02)</td><td>0.72</td></tr><tr><td>AOD 500</td><td>0.42 ± 0.14(0.69)</td><td>0.41 ± 0.15(0.75)</td><td>0.07 ± 0.06(0.27)</td><td>20.39 ± 22.07(105.7)</td><td>0.68</td></tr><tr><td>AOD 750</... |
1917f1135e0ec2e1c2bc0f3469dc2000652650e19498ddeb16e2490bf081f12d.png | complex | <table><tr><td></td><td></td><td>N =236</td><td>MV<sup>1</sup></td><td>Validation Sample S-QoL 18 matched by age and gender N=236</td></tr><tr><td>1. Sociodemographics</td><td></td><td>N (%)</td><td>%</td><td>N (%)</td></tr><tr><td>Gender</td><td>Men</td><td>205 (86.9)</td><td>0.0</td><td>205 (86.9)</td></tr><tr><td>Ag... | <table><tr><td></td><td></td><td>N =236</td><td>MV1</td><td>Validation Sample S-QoL 18 matched by age and gender N=236</td></tr><tr><td>1. Sociodemographics</td><td></td><td>N (%)</td><td>%</td><td>N (%)</td></tr><tr><td>Gender</td><td>Men</td><td>205 (86.9)</td><td>0.0</td><td>205 (86.9)</td></tr><tr><td>Age (years)</... | <table><tr><td></td><td></td><td>N =236</td><td>MV1</td><td>Validation Sample S-QoL 18 matched by age and gender N=236</td></tr><tr><td></td><td>l score</td><td>.4)</td><td></td><td></td></tr><tr><td>RAS4</td><td>Personal confidence and hope</td><td>31.7 (6.5)</td><td>20.8</td><td>NA</td></tr><tr><td></td><td>Willingne... |
9281ed724a72223ae0f88bfad647ad58d04972a98a462acf19e3edf66189742d.png | simple | <table><tr><td>Medium/Organism</td><td><i>Staphylococcus aureus</i></td><td><i>Staphylococcus epidermidis</i></td><td><i>Escherichia coli</i></td><td><i>Candida albicans</i></td></tr><tr><td>Mueller-Hinton agar</td><td>x</td><td>x</td><td>x</td><td>x</td></tr><tr><td>Blood agar</td><td>x</td><td>x</td><td>x</td><td></t... | <table><tr><td>Medium/Organism</td><td>Staphylococcus aureus</td><td>Staphylococcus epidermidis</td><td>Escherichia coli</td><td>Candida albicans</td></tr><tr><td>Mueller-Hinton agar</td><td>x</td><td>x</td><td>x</td><td>x</td></tr><tr><td>Blood agar</td><td>x</td><td>x</td><td>x</td><td></td></tr><tr><td>Blood agar-Na... | <table><tr><td> agar</td><td></td><td></td><td></td><td></td></tr><tr><td>Endo agar</td><td></td><td></td><td>x</td><td></td></tr></table> |
9129227e725f3a83db71382c92a36eaa7e9aa020144511739721a1e1632697a5.png | simple | <table><tr><td>Proposed legislation changes</td><td><underline>Utilitarian</underline></td><td><underline>++</underline></td><td><underline>+</underline></td><td><underline>0</underline></td><td><underline>-</underline></td><td><underline>--</underline></td><td><underline>Rights-focused</underline></td></tr><tr><td>Com... | <table><tr><td>Proposed legislation changes</td><td>Utilitarian</td><td>++</td><td>+</td></tr><tr><td>Community supervision</td><td></td><td>x</td><td></td></tr><tr><td>Broad definition of mental disorder</td><td></td><td>x</td><td></td></tr><tr><td>Detention of DSPD</td><td></td><td>x</td><td></td></tr><tr><td>More ge... | <table><tr><td>0</td><td>-</td><td>--</td><td>Rights-focused</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>x</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><t... |
25fbe92c674a843fe10c9b20685fee92340a46baadd483fbd7ce467a60b651fe.png | simple | <table><tr><td>Variable</td><td>Percent (%)</td></tr><tr><td>Fitzpatrick skin score grades 4 and 5 </td><td>79</td></tr><tr><td>Using sunscreen</td><td>24.2</td></tr><tr><td>Exposure to direct sunlight <15 min/day</td><td>71</td></tr><tr><td>Milk and milk product (servings/day)</td><td> </td></tr><tr><td> None</td><... | <table><tr><td>Variable</td><td>Percent (%)</td></tr><tr><td>Fitzpatrick skin score grades 4 and 5</td><td>79</td></tr><tr><td>Using sunscreen</td><td>24.2</td></tr><tr><td>Exposure to direct sunlight <15 min/day</td><td>71</td></tr></table> | <table><tr><td>Milk and milk product (servings/day)</td><td></td></tr><tr><td>None</td><td>23</td></tr><tr><td>1 to 2</td><td>64</td></tr><tr><td>3 to 4</td><td>9</td></tr><tr><td>>4</td><td>4</td></tr><tr><td>Fortified breakfast cereal (servings/week)</td><td></td></tr><tr><td>None</td><td>73.6</td></tr><tr><td>1 to 2... |
632246e5a41fd0c5034966b5fcf9e47fa72623695257831d9117f873387462b0.png | complex | <table><tr><td>Patient</td><td>Age</td><td>Clinical signs</td><td>Metal ions in peripheral blood</td><td>CRP (>5 mg/L)</td><td>White cell count (>10/nl)</td><td rowspan="2">Duration of implantation (years)</td><td>Articulating material</td></tr><tr><td colspan="3"> </td><td>a) Chrome (>7 μg/L)</td><td col... | <table><tr><td>Patient</td><td>Age</td><td>Clinical signs</td><td>Metal ions in peripheral blood</td><td>CRP (>5 mg/L)</td></tr><tr><td colspan="3"></td><td>a) Chrome (>7 μg/L)</td><td></td></tr><tr><td colspan="3"></td><td>b) Cobalt (>7 μg/L)</td><td></td></tr><tr><td>Metallosis</td><td></td><td></td><td></td><td></td... | <table><tr><td>White cell count (>10/nl)</td><td rowspan="2">Duration of implantation (years)</td><td>Articulating material</td></tr><tr><td></td><td></td></tr><tr><td colspan="3"></td></tr><tr><td></td><td></td><td></td></tr><tr><td>4.55/nl</td><td>8</td><td>Metal on metal</td></tr><tr><td colspan="3"></td></tr><tr><t... |
5d5f61477355e21fc9be88a1975190b928b4de1f6247de17b0c5e94419ff8cbe.png | simple | <table><tr><td>Antigen</td><td>Species</td><td>Source</td><td>Number</td><td>Dilution (Western)</td><td>Dilution (IHC)</td><td>Pepsin (IHC)</td></tr><tr><td>γ-2</td><td>Guinea pig</td><td>M. Watanabe</td><td>—</td><td>1:500</td><td>—</td><td>—</td></tr><tr><td>γ-2<i><sup>b</sup></i></td><td>... | <table><tr><td>Antigen</td><td>Species</td><td>Source</td><td>Number</td><td>Dilution (Western)</td><td>Dilution (IHC)</td><td>Pepsin (IHC)</td></tr><tr><td>γ-2</td><td>Guinea pig</td><td>M. Watanabe</td><td>—</td><td>1:500</td><td>—</td><td>—</td></tr><tr><td>γ-2b</td><td>Rabbit</td><td>Cell Signaling Technology</td><... | <table><tr><td>Antigen</td><td>Species</td><td>Source</td><td>Number</td><td>Dilution (Western)</td><td>Dilution (IHC)</td><td>Pepsin (IHC)</td></tr><tr><td>GluA1</td><td>Rabbit</td><td>Abcam</td><td>ab31232</td><td>—</td><td>1:500</td><td>Yes</td></tr><tr><td>GluA2</td><td>Mouse</td><td>Millipore</td><td>MAB397</td><t... |
50560d7161377c35de3d6b6d42fbb2110081890fccdafc309c83be32f75e9a72.png | simple | <table><tr><td></td><td>PEmb-QoL questions</td><td>Number of items</td><td>Cronbach’s alpha</td><td>Average inter-item correlation (r)</td></tr><tr><td>Frequency of complaints</td><td>Q1</td><td>8</td><td>0.90</td><td>0.52</td></tr><tr><td>Activities of daily living limitations</td><td>Q4</td><td>13</td><td>0.95<... | <table><tr><td></td><td>PEmb-QoL questions</td><td>Number of items</td><td>Cronbach’s alpha</td><td>Average inter-item correlation (r)</td></tr><tr><td>Frequency of complaints</td><td>Q1</td><td>8</td><td>0.90</td><td>0.52</td></tr><tr><td>Activities of daily living limitations</td><td>Q4</td><td>13</td><td>0.95</td><t... | <table><tr><td>Emotional complaints</td><td>Q9</td><td>10</td><td>0.92</td><td>0.52</td></tr><tr><td>PEmb-QoL summary score</td><td>Q1, Q4, Q5, Q6, Q7, Q8, Q9</td><td>38</td><td>0.92</td><td>0.44</td></tr></table> |
7869ccfc0760929422abaa91f4d279b12570d54b6714f05e9c0a90ce789f5b5c.png | simple | <table><tr><td>Patient no.</td><td>Diagnosis</td><td>Source</td><td>PB-blast%</td><td>BM-blast%</td><td>WBC</td><td>FAB</td><td>Cytogenetics</td><td>Status</td></tr><tr><td>1</td><td>AML</td><td>PB</td><td>92</td><td> </td><td> </td><td>M1</td><td>OD</td><td>New</td></tr><tr><td>2</td><td>AML</td><td>PB</td><td> </td><... | <table><tr><td>Patient no.</td><td>Diagnosis</td><td>Source</td><td>PB-blast%</td><td>BM-blast%</td></tr><tr><td>1</td><td>AML</td><td>PB</td><td>92</td><td></td></tr><tr><td>2</td><td>AML</td><td>PB</td><td></td><td></td></tr><tr><td>3</td><td>AML</td><td>PB</td><td>82</td><td>4.8</td></tr><tr><td>4</td><td>AML</td><t... | <table><tr><td>WBC</td><td>FAB</td><td>Cytogenetics</td><td>Status</td></tr><tr><td></td><td>M1</td><td>OD</td><td>New</td></tr><tr><td>331.08</td><td>M1</td><td>CD34-ANLL</td><td>New</td></tr><tr><td>81.5</td><td>M2b</td><td>FLT-ITD</td><td>New</td></tr><tr><td>29.5</td><td>M1</td><td>CEBPA mutation; BCR-ABL(9;22)(+)<... |
82222f50756cc95397fe5a3efc20812f338880fb7687de1883bbee7eb5389de7.png | complex | <table><tr><td colspan="2">Statement regarding condition</td><td></td><td></td><td colspan="2"></td></tr><tr><td colspan="2">With a typical asthmatic patient, how often do you actually talk about exercise?</td><td>Never or rarely: 12 (4.4)</td><td>Sometimes: 85 (31.1)</td><td colspan="2">Usually or always: 176 (64.5)</... | <table><tr><td colspan="2">Statement regarding condition</td><td></td><td></td><td colspan="2"></td></tr><tr><td colspan="2">With a typical asthmatic patient, how often do you actually talk about exercise?</td><td>Never or rarely: 12 (4.4)</td><td>Sometimes: 85 (31.1)</td><td colspan="2">Usually or always: 176 (64.5)</... | <table><tr><td colspan="2">How much training have you had on talking to asthmatic patients about exercise?</td><td>None: 90 (33.2)</td><td>Some: 116 (42.8)</td><td colspan="2">Extensive: 65 (24.0)</td></tr><tr><td colspan="2">Data presented as n (%)</td><td></td><td></td><td colspan="2"></td></tr><tr><td>Statement rega... |
320d8c30ccb7a3fb0864ded9c78e89789b7122943539887565e93f41bd89ab79.png | complex | <table><tr><td rowspan="2">Locus</td><td colspan="5"><i>P</i> Value</td></tr><tr><td>All HSR</td><td>SJS/TEN</td><td>DILI</td><td>NIR</td><td>HSS</td></tr><tr><td><i>HLA-A</i></td><td>894</td><td>.015</td><td>.429</td><td>.672</td><td>.135</td></tr><tr><td><i>HLA-B</i></td><td>111</td><td>.160</td><td>.068</td><td>.478... | <table><tr><td rowspan="2">Locus</td><td colspan="5">P Value</td></tr><tr><td>All HSR</td><td>SJS/TEN</td><td>DILI</td><td>NIR</td><td>HSS</td></tr><tr><td>HLA-A</td><td>894</td><td>.015</td><td>.429</td><td>.672</td><td>.135</td></tr></table> | <table><tr><td rowspan="2">Locus</td><td colspan="5">P Value</td></tr><tr><td>All HSR</td><td>SJS/TEN</td><td>DILI</td><td>NIR</td><td>HSS</td></tr><tr><td>HLA-B</td><td>111</td><td>.160</td><td>.068</td><td>.478</td><td>.066</td></tr><tr><td>HLA-C</td><td>036</td><td>.014</td><td>.179</td><td>.489</td><td>.564</td></t... |
1d89cc235849edd2457a148cf6bf5e0616b409ddf112b2d257555aaacee17ae8.png | simple | <table><tr><td>Damage Case</td><td>I</td><td>D1</td><td>D2</td><td>D3</td><td>D4</td><td>D5</td><td>D6</td><td>D7</td><td>D8</td></tr><tr><td>Damage quantity of E<sub>3</sub> (%)</td><td>0</td><td>3 </td><td>5 </td><td>15 </td><td>18 </td><td>18 </td><td>18 </td><td>18 </td><td>18 </td></tr><tr><td>Damage quantity of E... | <table><tr><td>Damage Case</td><td>I</td></tr><tr><td>Damage quantity of E3 (%)</td><td>0</td></tr><tr><td>Damage quantity of E7 (%)</td><td>0</td></tr></table> | <table><tr><td>D1</td><td>D2</td><td>D3</td><td>D4</td><td>D5</td><td>D6</td><td>D7</td><td>D8</td></tr><tr><td>3</td><td>5</td><td>15</td><td>18</td><td>18</td><td>18</td><td>18</td><td>18</td></tr><tr><td>0</td><td>0</td><td>0</td><td>0</td><td>3</td><td>5</td><td>15</td><td>18</td></tr></table> |
70c7902d8a7501e653c9e169b9b5fccd686a9ddd135d423153bd925dd7b0bfa5.png | simple | <table><tr><td>Steps</td><td>Selected questions and issues raised by the example case study “Maria Morales”</td></tr><tr><td>1. <i>Identify and frame in own words</i>: What is the underlying moral conflict?</td><td>Can a parents’ right to not have an intervention done with their child be overridden by... | <table><tr><td>Steps</td></tr><tr><td>1. Identify and frame in own words: What is the underlying moral conflict?</td></tr><tr><td>2. Identify and frame in ethical words: Which ethical principles are relevant, how can they be specified and might they be in conflict to each other?</td></tr><tr><td>3. Zoom further in: Do ... | <table><tr><td>Selected questions and issues raised by the example case study “Maria Morales”</td></tr><tr><td>Can a parents’ right to not have an intervention done with their child be overridden by the state (for someone else’s good)? Furthermore: Can parents exercise their will on behalf of their children?</td></tr><... |
c63a812f5e6feed784d0287db8dc147beabb6f4abdc8ad0b1e49fd09e2bcc6a7.png | simple | <table><tr><td>GenBank Accession Number</td><td>Previous name</td><td>New name</td></tr><tr><td>CAA78718</td><td><i>X. laevis </i>Apx</td><td>xShroom1</td></tr><tr><td>NP_597713</td><td><i>H. sapiens </i>APXL2</td><td>hShroom1</td></tr><tr><td>CAA58534</td><td><i>H. sapiens </i>APXL</td><td>hShroom2</td></tr><tr><td>AB... | <table><tr><td>GenBank Accession Number</td><td>Previous name</td><td>New name</td></tr></table> | <table><tr><td>CAA78718</td><td>X. laevis Apx</td><td>xShroom1</td></tr><tr><td>NP_597713</td><td>H. sapiens APXL2</td><td>hShroom1</td></tr><tr><td>CAA58534</td><td>H. sapiens APXL</td><td>hShroom2</td></tr><tr><td>ABD19518</td><td>M. musculus Apxl</td><td>mShroom2</td></tr><tr><td>AAF13269</td><td>M. musculus ShroomL... |
15a022d26cefe9f752da56975ebcff96c8a7f64725342e2489aef48e40388eaf.png | complex | <table><tr><td>Family</td><td>Plant species</td><td>Plant part</td><td>Extraction</td><td colspan="3">Repellency%</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="3">(minutes post application)</td></tr><tr><td></td><td></td><td></td><td></td><td>60</td><td>120</td><td>180</td></tr><tr><td>Asteraceae</td><t... | <table><tr><td>Family</td><td>Plant species</td><td>Plant part</td><td>Extraction</td><td colspan="3">Repellency%</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="3">(minutes post application)</td></tr><tr><td></td><td></td><td></td><td></td><td>60</td><td>120</td><td>180</td></tr><tr><td>Asteraceae</td><t... | <table><tr><td>Family</td><td>Plant species</td><td>Plant part</td><td>Extraction</td><td colspan="3">Repellency%</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="3">(minutes post application)</td></tr><tr><td></td><td></td><td></td><td></td><td>60</td><td>120</td><td>180</td></tr><tr><td>Buddlejaceae</td>... |
a49590db7b9ccc0a06682512f77d11f5da5323a333fd584713c90d14e523087a.png | complex | <table><tr><td>Gender</td><td> </td><td> </td><td colspan="2">Age range (percentage)</td><td> </td><td> </td><td>Total</td></tr><tr><td> </td><td>0-6</td><td>7-13</td><td>14-21</td><td>22-29</td><td>30-40</td><td>> 40</td><td></td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </... | <table><tr><td>Gender</td><td></td><td></td><td colspan="2">Age range (percentage)</td><td></td><td></td></tr><tr><td></td><td>0-6</td><td>7-13</td><td>14-21</td><td>22-29</td><td>30-40</td><td>> 40</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td>56 (24.1)</td><td... | <table><tr><td>Total</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>232 (100)</td></tr><tr><td>415 (100)</td></tr><tr><td>647 (100)</td></tr></table> |
e209586cecafff55c0a0ef0abdc3f9382d2659cfa2d566b5d81812453b33588b.png | simple | <table><tr><td></td><td>Area</td><td>Layer</td><td>Area * Layer</td></tr><tr><td>Squirrel monkey</td><td><i>F</i><sub>(3, 6)</sub> = 34.15, <i>p</i> < 0.01<sup>*</sup></td><td><i>F</i><sub>(1, 6)</sub> = 21.43, <i>p</i> = 0.04<sup>*</sup></td><td><i>F</i><sub>(3, 6)</sub> = 3.59, <i>p</i> = 0.09</td></tr><tr><td>Cap... | <table><tr><td></td></tr><tr><td>Squirrel monkey</td></tr><tr><td>Capuchin</td></tr><tr><td>Moor macaque</td></tr><tr><td>Pigtailed macaque</td></tr><tr><td>Baboon</td></tr><tr><td>Gorilla</td></tr><tr><td>Chimpanzee</td></tr><tr><td>Human</td></tr></table> | <table><tr><td>Area</td><td>Layer</td><td>Area * Layer</td></tr><tr><td>F(3, 6) = 34.15, p < 0.01*</td><td>F(1, 6) = 21.43, p = 0.04*</td><td>F(3, 6) = 3.59, p = 0.09</td></tr><tr><td>F(3, 9) = 5.58, p = 0.02*</td><td>F(1, 9) = 20.01, p = 0.02*</td><td>F(3, 9) = 14.17, p < 0.01*</td></tr><tr><td>F(3, 9) = 6.29, p = 0.0... |
9f27fdeba510f5735e90824277ad7f5fa88b1ce25fc3443b60891adcd3e1f035.png | complex | <table><tr><td rowspan="3">HD score grade</td><td colspan="9">Breed</td><td rowspan="3">Total</td></tr><tr><td>Boxer</td><td>Doberman</td><td>Great Dane</td><td>Golden Retriever</td><td>German Shepherd</td><td>Hungarian Vizla</td><td>Labrador Retriever</td><td>Rottweiler</td><td>Rhodesian Ridgeback</td></tr><tr><td>>... | <table><tr><td rowspan="3">HD score grade</td><td colspan="9">Breed</td><td rowspan="3">Total</td></tr><tr><td>Boxer</td><td>Doberman</td><td>Great Dane</td><td>Golden Retriever</td><td>German Shepherd</td><td>Hungarian Vizla</td><td>Labrador Retriever</td><td>Rottweiler</td><td>Rhodesian Ridgeback</td></tr><tr><td col... | <table><tr><td>>18</td><td>-</td><td>1</td><td>-</td><td>-</td><td>77</td><td></td><td>10</td><td>10</td><td>-</td><td>98</td></tr><tr><td>13-18</td><td>-</td><td>-</td><td>1</td><td>1</td><td>139</td><td>1</td><td>26</td><td>22</td><td>3</td><td>193</td></tr><tr><td>9-12</td><td>3</td><td>5</td><td>2</td><td>-</td><td... |
7212a0639acfe6734a8dafaf332ae2bcb0991be2ea80609dfbf11500e605ef9f.png | complex | <table><tr><td></td><td colspan="2">Pain increase at 6-weeks.</td><td colspan="2">Pain increase at 6-months.</td></tr><tr><td></td><td>NRS Points (95% confidence interval)</td><td><i>P</i> value</td><td>NRS Points (95% confidence interval)</td><td><i>P</i> value</td></tr><tr><td>Preoperative anxiety (yes/no)</td><td>&#... | <table><tr><td></td><td colspan="2">Pain increase at 6-weeks.</td><td colspan="2">Pain increase at 6-months.</td></tr><tr><td></td><td>NRS Points (95% confidence interval)</td><td>P value</td><td>NRS Points (95% confidence interval)</td><td>P value</td></tr><tr><td>Preoperative anxiety (yes/no)</td><td>−.30 (−1.22–.63)... | <table><tr><td>Intercept</td><td>3.04 (−.56–6.64)</td><td>.10</td><td>− 1.96 (−6.02–2.10)</td><td>.34</td></tr></table> |
8bff07182aeadd56b8bda673f1074d1e9c1032004460fe6969ec0c94c0ed3d1a.png | simple | <table><tr><td>Antibodies</td><td>Species</td><td>Dilution</td><td>Source</td><td>Code no.</td></tr><tr><td>P2X2</td><td>Rabbit</td><td>1:100</td><td>Alomone</td><td>APR-003</td></tr><tr><td>IP<sub>3</sub>R3</td><td>Mouse</td><td>1:100</td><td>Transduction Lab.</td><td>610313</td></tr><tr><td>Syntaxin-1</td><td>Mouse</... | <table><tr><td>Antibodies</td><td>Species</td><td>Dilution</td><td>Source</td><td>Code no.</td></tr><tr><td>P2X2</td><td>Rabbit</td><td>1:100</td><td>Alomone</td><td>APR-003</td></tr><tr><td>IP3R3</td><td>Mouse</td><td>1:100</td><td>Transduction Lab.</td><td>610313</td></tr><tr><td>Syntaxin-1</td><td>Mouse</td><td>1:10... | <table><tr><td>Antibodies</td><td>Species</td><td>Dilution</td><td>Source</td><td>Code no.</td></tr><tr><td>Serotonin</td><td>Mouse</td><td>1:100</td><td>Abcam</td><td>ab16007</td></tr></table> |
a3993fcfaa06986b3686217b9afed42c302d0be0328aeb88bd0afaac1fa0fa1f.png | complex | <table><tr><td>No.</td><td>Statement</td><td>Rank</td><td>Z-score</td></tr><tr><td colspan="4">Defining statements</td></tr><tr><td colspan="4">Agrees strongly with the following statements</td></tr><tr><td>12</td><td>I value more time for my personal life</td><td>3</td><td>1.59</td></tr><tr><td>16</td><td>I want to be... | <table><tr><td>No.</td><td>Statement</td></tr><tr><td colspan="2">Defining statements</td></tr><tr><td colspan="2">Agrees strongly with the following statements</td></tr><tr><td>12</td><td>I value more time for my personal life</td></tr><tr><td>16</td><td>I want to be in a large city</td></tr><tr><td>32</td><td>The fac... | <table><tr><td>Rank</td><td>Z-score</td></tr><tr><td colspan="2">Defining statements</td></tr><tr><td colspan="2">Agrees strongly with the following statements</td></tr><tr><td>3</td><td>1.59</td></tr><tr><td>3</td><td>1.53</td></tr><tr><td>2</td><td>1.20</td></tr><tr><td>2</td><td>1.13</td></tr><tr><td>2</td><td>1.12<... |
3954499afae4da97ac79c6943be4602d018d38cf8752edfded186cab584fc740.png | complex | <table><tr><td rowspan="2">Culture days</td><td colspan="2">Control explants</td><td colspan="2">Explants+MNF</td></tr><tr><td>Cultured</td><td>Lost</td><td>Cultured</td><td>Lost</td></tr><tr><td>3</td><td>25</td><td>1</td><td>13</td><td>0</td></tr><tr><td>6</td><td>25</td><td>3</td><td>13</td><td>1</td></tr><tr><td>9<... | <table><tr><td rowspan="2">Culture days</td><td>Control explants</td></tr><tr><td>Cultured</td></tr><tr><td>3</td><td>25</td></tr><tr><td>6</td><td>25</td></tr><tr><td>9</td><td>25</td></tr><tr><td></td><td>75</td></tr><tr><td colspan="2">Total: 114 explants</td></tr></table> | <table><tr><td>Control explants</td><td colspan="2">Explants+MNF</td></tr><tr><td>Lost</td><td>Cultured</td><td>Lost</td></tr><tr><td>1</td><td>13</td><td>0</td></tr><tr><td>3</td><td>13</td><td>1</td></tr><tr><td>4</td><td>13</td><td>1</td></tr><tr><td>8</td><td>39</td><td>2</td></tr><tr><td colspan="3">Total: 114 exp... |
5adc3ca3fa985524560d26e4b7bc754a392748fd90be0240e68198f354869f9b.png | complex | <table><tr><td colspan="9"><i>3rd level ATC Code Prediction using different initializations and comparison to STP</i></td></tr><tr><td><i>Initialization method</i></td><td colspan="2"><i>Supervised learning</i></td><td colspan="2"><i>SuperPred</i></td><td colspan="2"><i>ChEMBL (Perfect 1st level)</i></td><td colspan="2... | <table><tr><td colspan="9">3rd level ATC Code Prediction using different initializations and comparison to STP</td></tr><tr><td>Initialization method</td><td colspan="2">Supervised learning</td><td colspan="2">SuperPred</td><td colspan="2">ChEMBL (Perfect 1st level)</td><td colspan="2">STP</td></tr><tr><td>Prediction m... | <table><tr><td>MLP</td><td>63.62%</td><td>68.82%(57.16%)</td><td>63.26%</td><td>70.67%(58.24%)</td><td>72.40%</td><td>83.81%(66.67%)</td><td>72.40%</td><td>73.42%(59.14%)</td></tr><tr><td>Naive Bayes</td><td>56.99%</td><td>50.96%(31.00%)</td><td>66.49%</td><td>68.22%(46.59%)</td><td>69.00%</td><td>78.14%(52.51%)</td><t... |
53360da7bad0adaa0de107a2db293e475261d0d9910c6260d31238078bda1cd9.png | complex | <table><tr><td rowspan="2"> </td><td colspan="3">Multivariate</td></tr><tr><td>Odds ratio</td><td>95% CI</td><td>p</td></tr><tr><td>Sm</td><td>0.391</td><td>0.145-1.056</td><td>0.064</td></tr><tr><td>Global longitudinal strain</td><td>1.457</td><td>1.002-2.119</td><td>0.049</td></tr><tr><td>Global circumferential strai... | <table><tr><td rowspan="2"></td><td colspan="3">Multivariate</td></tr><tr><td>Odds ratio</td><td>95% CI</td><td>p</td></tr><tr><td>Sm</td><td>0.391</td><td>0.145-1.056</td><td>0.064</td></tr><tr><td>Global longitudinal strain</td><td>1.457</td><td>1.002-2.119</td><td>0.049</td></tr><tr><td>Global circumferential strain... | <table><tr><td>Global radial strain</td><td>0.952</td><td>0.818-1.107</td><td>0.533</td></tr></table> |
f3821736100300a5aa43536356e1a6b834fb699e9a724d117a8245a093ab1c32.png | complex | <table><tr><td rowspan="3">Body site</td><td colspan="3">Number of pain sites</td></tr><tr><td>1</td><td>2–3</td><td>>4</td></tr><tr><td>%</td><td>%</td><td>%</td></tr><tr><td>Neck</td><td>9.5</td><td>46.9</td><td>43.6</td></tr><tr><td>Shoulder</td><td>16.8</td><td>38.2</td><td>45.0</td></tr><tr><td>Upper back... | <table><tr><td rowspan="3">Body site</td></tr><tr></tr><tr></tr><tr><td>Neck</td></tr><tr><td>Shoulder</td></tr><tr><td>Upper back</td></tr><tr><td>Upper limbs</td></tr><tr><td>Low back</td></tr><tr><td>Upper leg/ knee</td></tr><tr><td>Lower Leg</td></tr><tr><td>Ankle/Feet</td></tr></table> | <table><tr><td colspan="3">Number of pain sites</td></tr><tr><td>1</td><td>2–3</td><td>>4</td></tr><tr><td>%</td><td>%</td><td>%</td></tr><tr><td>9.5</td><td>46.9</td><td>43.6</td></tr><tr><td>16.8</td><td>38.2</td><td>45.0</td></tr><tr><td>16.6</td><td>39.8</td><td>43.6</td></tr><tr><td>23.7</td><td>42.4</td><td>33.9<... |
7571e43d4e4dabfaa6fff2c2f0e716b1011663c5ef0425c0d00c981cf81905f0.png | complex | <table><tr><td rowspan="2">Average computation times [sec]</td><td colspan="2">Fully automatic</td><td colspan="2">Semi-automatic</td></tr><tr><td>CPU</td><td>GPU</td><td>CPU</td><td>GPU</td></tr><tr><td>Linear registration</td><td>112</td><td>109</td><td>140</td><td>130</td></tr><tr><td>Nonlinear registration</td><td>... | <table><tr><td rowspan="2">Average computation times [sec]</td><td colspan="2">Fully automatic</td><td colspan="2">Semi-automatic</td></tr><tr><td>CPU</td><td>GPU</td><td>CPU</td><td>GPU</td></tr></table> | <table><tr><td>Linear registration</td><td>112</td><td>109</td><td>140</td><td>130</td></tr><tr><td>Nonlinear registration</td><td>172</td><td>145</td><td>176</td><td>173</td></tr><tr><td>Combining transformations</td><td>42</td><td>42</td><td>42</td><td>42</td></tr><tr><td>Warping of image channels</td><td>79</td><td>... |
0e365fb9621fc22646cea8563346aa9ea4f206b8444b4617cec1156460986adc.png | simple | <table><tr><td>1a/2a/STAB ratio (mmol/mmol/mmol)</td><td>Solvent (mL)</td><td>Catalyst</td><td>Reaction time (h)</td><td>Yield<sup>a</sup> (%)</td></tr><tr><td>1/1/1</td><td>THF</td><td>–</td><td>50</td><td>42</td></tr><tr><td>1/1/1.45</td><td>THF</td><td>–</td><td>50</td><td>61</td></tr><tr><td>1/1/1</td><... | <table><tr><td>1a/2a/STAB ratio (mmol/mmol/mmol)</td><td>Solvent (mL)</td><td>Catalyst</td><td>Reaction time (h)</td><td>Yielda (%)</td></tr><tr><td>1/1/1</td><td>THF</td><td>–</td><td>50</td><td>42</td></tr><tr><td>1/1/1.45</td><td>THF</td><td>–</td><td>50</td><td>61</td></tr><tr><td>1/1/1</td><td>DCE</td><td>–</td><t... | <table><tr><td>1/1/1.5</td><td>DCE</td><td>AcOH</td><td>4</td><td>98</td></tr></table> |
37baa1c47113cd93862e896e96e03477c69a3e438d0b930aae6290b848d3b6f5.png | complex | <table><tr><td><i>Characteristic</i></td><td colspan="2"><i>Healthy weight</i></td><td colspan="2"><i>Overweight</i></td><td colspan="2"><i>Obese</i></td></tr><tr><td> </td><td>n</td><td><i>Mean (s.d.)</i></td><td>n</td><td><i>Mean (s.d.)</i></td><td>n</td><td><i>Mean (s.d.)</i></td></tr><tr><td>Age in months at weight... | <table><tr><td>Characteristic</td><td colspan="2">Healthy weight</td><td colspan="2">Overweight</td><td colspan="2">Obese</td></tr><tr><td></td><td>n</td><td>Mean (s.d.)</td><td>n</td><td>Mean (s.d.)</td><td>n</td><td>Mean (s.d.)</td></tr><tr><td>Age in months at weight status measurement</td><td>4259</td><td>140.94 (2... | <table><tr><td>CBSE</td><td>462</td><td>11.8</td><td>103</td><td>14.3</td><td>142</td><td>17.7</td></tr><tr><td>Vocational</td><td>313</td><td>8.0</td><td>64</td><td>8.9</td><td>81</td><td>10.1</td></tr><tr><td>O level</td><td>1381</td><td>35.3</td><td>270</td><td>37.5</td><td>304</td><td>37.8</td></tr><tr><td>A level<... |
579bf68453c8f4c7cd193bdd40aa4c861f1ede5c0a954916bec42e354aa804ca.png | simple | <table><tr><td>Characteristics</td><td>Number</td><td>Percentage (%)</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Male</td><td>60</td><td>70.6</td></tr><tr><td>Female</td><td>25</td><td>29.4</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td>≤ 60</td><td>53</td><td>62.4</td></tr><tr><td>> 60... | <table><tr><td>Characteristics</td><td>Number</td><td>Percentage (%)</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Male</td><td>60</td><td>70.6</td></tr><tr><td>Female</td><td>25</td><td>29.4</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td>≤ 60</td><td>53</td><td>62.4</td></tr><tr><td>> 60</td><td>... | <table><tr><td>Adenocarcinoma</td><td>60</td><td>70.6</td></tr><tr><td>Differentiation</td><td></td><td></td></tr><tr><td>Well and moderate</td><td>58</td><td>68.2</td></tr><tr><td>Poor</td><td>27</td><td>31.8</td></tr><tr><td>Metastasis lymphatics</td><td></td><td></td></tr><tr><td>Yes</td><td>28</td><td>32.9</td></tr... |
6c9a68531f00a5fcf41d8bfa2d7d0254131f004afab311903ea1fb25323a08dd.png | complex | <table><tr><td> </td><td rowspan="2" colspan="3">All studies</td><td colspan="6">Level of methodological quality</td></tr><tr><td> </td><td colspan="3">Poor</td><td colspan="3">Fair to good</td></tr><tr><td> </td><td>Acceptable</td><td>Total</td><td>% Acceptable</td><td>Acceptable</td><td>Total</td><td>% Acceptable</td... | <table><tr><td></td><td rowspan="2" colspan="3">All studies</td><td colspan="6">Level of methodological quality</td></tr><tr><td></td><td colspan="3">Poor</td><td colspan="3">Fair to good</td></tr><tr><td></td><td>Acceptable</td><td>Total</td><td>% Acceptable</td><td>Acceptable</td><td>Total</td><td>% Acceptable</td><t... | <table><tr><td></td><td rowspan="2" colspan="3">All studies</td><td colspan="6">Level of methodological quality</td></tr><tr><td></td><td colspan="3">Poor</td><td colspan="3">Fair to good</td></tr><tr><td></td><td>Acceptable</td><td>Total</td><td>% Acceptable</td><td>Acceptable</td><td>Total</td><td>% Acceptable</td><t... |
d8f63de0a5a5a8177b754ec5060ed17906ba9a941892fdb12839267e37155a31.png | complex | <table><tr><td rowspan="3"></td><td colspan="2">BMI <18.5</td><td colspan="2">BMI 18.5–24.9</td><td colspan="2">BMI 25–29.9</td><td colspan="2">BMI ≥ 30</td><td rowspan="3"></td></tr><tr><td colspan="2">Underweight</td><td colspan="2">Normal</td><td colspan="2">Overweight</td><td colspan="2">Obesit... | <table><tr><td rowspan="3"></td><td colspan="2">BMI <18.5</td><td colspan="2">BMI 18.5–24.9</td><td colspan="2">BMI 25–29.9</td><td colspan="2">BMI ≥ 30</td><td rowspan="3"></td></tr><tr><td colspan="2">Underweight</td><td colspan="2">Normal</td><td colspan="2">Overweight</td><td colspan="2">Obesity</td></tr><tr><td co... | <table><tr><td>Chylothorax</td><td>10</td><td>2.5</td><td>7</td><td>1.1</td><td>6</td><td>1.4</td><td>4</td><td>5.9</td><td>0.062</td></tr><tr><td>Atelectasis</td><td>00</td><td>0.0</td><td>7</td><td>1.1</td><td>6</td><td>1.4</td><td>2</td><td>2.9</td><td>0.481</td></tr></table> |
aa46315b259d50914aee8e870911ce4b1778ae8b86958c714dca0002783e36b2.png | simple | <table><tr><td>Experiment</td><td>Climate<sup>a</sup></td><td>Land cover<sup>b</sup></td><td>Managed grassland area<sup>c</sup></td><td>Atmospheric CO<sub>2</sub> concentration</td><td>Management strategy</td></tr><tr><td><i>E</i><sub><i>hist</i></sub><sup>d</sup></td><td>Varied for 1901–2010</td><td>Varied for 1... | <table><tr><td>Experiment</td><td>Climatea</td><td>Land coverb</td><td>Managed grassland areac</td><td>Atmospheric CO2 concentration</td><td>Management strategy</td></tr><tr><td>Ehist</td><td></td><td>Varied for </td><td>Varied </td><td>Varied for 19</td><td>Adaptive management change algorithm simulating potential liv... | <table><tr><td>d</td><td>Varied for 1901–2010</td><td>1901–2010</td><td>for 1901–2010</td><td>01–2010</td><td>ck density</td></tr><tr><td>Econtrol</td><td>Varied for 2011–2100</td><td>Constant as in 2010</td><td>Constant as in 2010</td><td>Varied for 2011–2100 (A1B scenario)</td><td>Adaptive management change algorithm... |
ac3148737eaa2be741bd891cfe33edc374d9540c7f33dbc603fa727b89081030.png | complex | <table><tr><td></td><td></td><td></td><td colspan="3">Log<sub>2</sub>(ratio)</td></tr><tr><td>Accession number</td><td>Gene description</td><td>Localisation</td><td colspan="3">Treatment comparison</td></tr><tr><td></td><td></td><td></td><td>S/M</td><td>MA/M</td><td>SA/M</td></tr><tr><td>At1g57770</td><td>Amine oxidase... | <table><tr><td></td><td></td></tr><tr><td>Accession number</td><td>Gene description</td></tr><tr><td></td><td></td></tr><tr><td>At1g57770</td><td>Amine oxidase family</td></tr><tr><td>At3g14420</td><td>(S)-2-hydroxy-acid oxidase, peroxisomal, putative/glycolate oxidase, putative/short chain alpha-hydroxy acid oxidase, ... | <table><tr><td></td><td colspan="3">Log2(ratio)</td></tr><tr><td>Localisation</td><td colspan="3">Treatment comparison</td></tr><tr><td></td><td>S/M</td><td>MA/M</td><td>SA/M</td></tr><tr><td>Chloroplast</td><td>nde</td><td>1.59</td><td>0.80</td></tr><tr><td>Peroxisome</td><td>-1.08</td><td>1.33</td><td>nde</td></tr><t... |
c97a565cd943d61e1a695fc6e05e36522fdf6810c6d95f153c5bdc33f0c0c157.png | simple | <table><tr><td>Reference</td><td>No. of case reports</td><td>Patient case conditions</td><td>Prophylaxis used</td><td>Treatment that cleared infection</td><td>Isolate(s) cultured</td><td>Geographic location</td><td>Year published</td></tr><tr><td>Wang et al., 2011</td><td>1</td><td>Mandibulectomy with planned tissue fl... | <table><tr><td>Reference</td><td>No. of case reports</td><td>Patient case conditions</td></tr><tr><td>Wang et al., 2011</td><td>1</td><td>Mandibulectomy with planned tissue flap reconstruction, infection and necrosis of the flap</td></tr><tr><td>Sartor et al., 2013</td><td>1</td><td>Infection of skin flap of hand crush... | <table><tr><td>Prophylaxis used</td><td>Treatment that cleared infection</td><td>Isolate(s) cultured</td><td>Geographic location</td><td>Year published</td></tr><tr><td>Ciprofloxacin</td><td>Cefepime</td><td>A. hydrophila</td><td>Missouri, USA</td><td>2011</td></tr><tr><td>Ciprofloxacin</td><td>Cotrimoxazole</td><td>A.... |
e0a2acc1fbd61ce400f634059ed3d27d15ece6fcddc0cfb34875aaf292de56d3.png | complex | <table><tr><td>Subscale</td><td>Group</td><td>Baseline score</td><td>One month after the onset of intervention</td><td>Two months after the onset of intervention</td><td>Between groups difference</td></tr><tr><td rowspan="2">Irritability</td><td>N-Acetylcysteine + risperidone</td><td>13.2(5.3)</td><td>10.0(4.1)</td><td... | <table><tr><td>Subscale</td><td>Group</td><td>Baseline score</td><td>One month after the onset of intervention</td><td>Two months after the onset of intervention</td><td>Between groups difference</td></tr><tr><td rowspan="2">Irritability</td><td>N-Acetylcysteine + risperidone</td><td>13.2(5.3)</td><td>10.0(4.1)</td><td... | <table><tr><td>Inappropriate Speech</td><td>Placebo+Risperidone</td><td>5.7(3.8)</td><td>5.3(3.7)</td><td>5.2(4.0)</td><td>F1,29= 1.8, P=0.1</td></tr></table> |
0565e4af8e09eb7656adf93e37908277f38a5ae9cd46a0352d707ea39d713530.png | simple | <table><tr><td></td><td>Weaned pigs</td><td>Growing pigs</td><td>Gilts</td></tr><tr><td>Number of animals</td><td>9 (6 to 11)</td><td>23 (20 to 25)</td><td>24 (18 to 29)</td></tr><tr><td>Degree</td><td></td><td></td><td></td></tr><tr><td>Binary</td><td>7<sup>a</sup> (0 to 16)</td><td>5<sup>b</sup> (1 to 18)</td><td>5<s... | <table><tr><td></td><td>Weaned pigs</td><td>Growing pigs</td><td>Gilts</td></tr><tr><td>Number of animals</td><td>9 (6 to 11)</td><td>23 (20 to 25)</td><td>24 (18 to 29)</td></tr><tr><td>Degree</td><td></td><td></td><td></td></tr><tr><td>Binary</td><td>7a (0 to 16)</td><td>5b (1 to 18)</td><td>5b (0 to 22)</td></tr></t... | <table><tr><td></td><td>Weaned pigs</td><td>Growing pigs</td><td>Gilts</td></tr><tr><td>Weighted</td><td>12a (0 to 96)</td><td>5b (1 to 27)</td><td>5b (0 to 36)</td></tr><tr><td>In-degree</td><td></td><td></td><td></td></tr><tr><td>Binary</td><td>4a (0 to 8)</td><td>3b (0 to 11)</td><td>3b (0 to 11)</td></tr><tr><td>We... |
d1d1c3e520d04321119f8969a28d7c44e97f7cf92d18b7092ee158abbde221a7.png | complex | <table><tr><td>Region</td><td>Side</td><td colspan="3">MNI coordinates</td><td><i>T</i> value</td></tr><tr><td>Pre-cuneus</td><td>R</td><td>4</td><td>-70</td><td>36</td><td>32.78</td></tr><tr><td></td><td>L</td><td>-7</td><td>-74</td><td>42</td><td>32.12</td></tr><tr><td>Cuneus</td><td>R</td><td>10</td><td>76</td><td>3... | <table><tr><td>Region</td></tr><tr><td>Pre-cuneus</td></tr><tr><td></td></tr><tr><td>Cuneus</td></tr><tr><td></td></tr><tr><td>Inferior temporal gyrus area (includes fusiform gyrus)</td></tr><tr><td></td></tr><tr><td>Pre-central gyrus</td></tr><tr><td>Post-central gyrus</td></tr><tr><td>Superior temporal gyrus</td></tr... | <table><tr><td>Side</td><td colspan="3">MNI coordinates</td><td>T value</td></tr><tr><td>R</td><td>4</td><td>-70</td><td>36</td><td>32.78</td></tr><tr><td>L</td><td>-7</td><td>-74</td><td>42</td><td>32.12</td></tr><tr><td>R</td><td>10</td><td>76</td><td>38</td><td>32.62</td></tr><tr><td>L</td><td>-10</td><td>-68</td><t... |
6b580ef0894dcbe03677d52b6cc29d9134c638ddd0c7cb669ac9296d658ef3bc.png | complex | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">No. of cases</td><td colspan="2">miR-140 expression</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>Low (median ≤0.278)</td><td>High (median >0.278)</td></tr><tr><td colspan="4">Age</td><td>0.667</td></tr><tr><td>< 60 years</td><td>22</td><t... | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">No. of cases</td><td colspan="2">miR-140 expression</td><td rowspan="2">P value</td></tr><tr><td>Low (median ≤0.278)</td><td>High (median >0.278)</td></tr><tr><td colspan="4">Age</td><td>0.667</td></tr><tr><td>< 60 years</td><td>22</td><td>10</td><td>12</td... | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">No. of cases</td><td colspan="2">miR-140 expression</td><td rowspan="2">P value</td></tr><tr><td>Low (median ≤0.278)</td><td>High (median >0.278)</td></tr><tr><td>Poor</td><td>36</td><td>15</td><td>21</td><td></td></tr><tr><td colspan="4">Metastasis</td><td... |
ec534edd8cda722785af998365edc865aa498132fa5d55b7487083bad239be50.png | simple | <table><tr><td>Absolute Contraindications</td><td>Relative Contraindications</td></tr><tr><td>Clinical instability or significant pain suggestive of ruptured EP</td><td>Presence of fetal cardiac activity</td></tr><tr><td>Heterotopic pregnancy with viable and desired IUP</td><td>β-hCG level over 5000 mIU/mL</td></t... | <table><tr><td>Absolute Contraindications</td><td>Relative Contraindications</td></tr><tr><td>Clinical instability or significant pain suggestive of ruptured EP</td><td>Presence of fetal cardiac activity</td></tr><tr><td>Heterotopic pregnancy with viable and desired IUP</td><td>β-hCG level over 5000 mIU/mL</td></tr><tr... | <table><tr><td>Platelet count <100,000/uL</td><td>Patient inability to follow up</td></tr><tr><td>Creatinine ≥1.5 mg/dL</td><td></td></tr><tr><td>Current breastfeeding</td><td></td></tr><tr><td>Active pulmonary disease</td><td></td></tr><tr><td>Active peptic ulcer disease</td><td></td></tr><tr><td>Moderate to severe an... |
1c239423b2cd66cc03f230637ad62b1c24cf045849b03f653527c763e125a8b4.png | complex | <table><tr><td>Item</td><td>Details</td><td>Intervention</td></tr><tr><td rowspan="3">1. Acupuncture rationale</td><td>1a) Style of acupuncture</td><td>Traditional needle acupuncture and intradermal acupuncture</td></tr><tr><td>1b) Reasoning for treatment provided based on historical context, literature sources, and/or... | <table><tr><td>Item</td><td>Details</td></tr><tr><td rowspan="3">1. Acupuncture rationale</td><td>1a) Style of acupuncture</td></tr><tr><td>1b) Reasoning for treatment provided based on historical context, literature sources, and/or consensus methods, with references where appropriate</td></tr><tr><td>1c) Extent to whi... | <table><tr><td>Intervention</td></tr><tr><td>Traditional needle acupuncture and intradermal acupuncture</td></tr><tr><td>Selected traditional acupuncture points on the 12 meridian system based on the systematic review by Yeung and clinical experiences</td></tr><tr><td>No variation</td></tr><tr><td>Five needle insertion... |
087e3a3bf156d24dee02216661e52daaf087f681abfa04dbd92b900845a377ad.png | complex | <table><tr><td>Date</td><td>Flight Time</td><td>τ (95% Confidence Bounds)</td><td>L<sub>u</sub> (95% Confidence Bounds) W/m<sup>2</sup>/μm/sr</td><td>r<sup>2</sup></td><td>RMSE W/m<sup>2</sup>/μm/sr</td><td>Used Pixels</td></tr><tr><td rowspan="2">8/9/2014</td><td>Early Morning</td><td>0.40 (0.51 0.33)</... | <table><tr><td>Date</td><td>Flight Time</td><td>τ (95% Confidence Bounds)</td><td>Lu (95% Confidence Bounds) W/m2/μm/sr</td><td>r2</td><td>RMSE W/m2/μm/sr</td><td>Used Pixels</td></tr><tr><td rowspan="2">8/9/2014</td><td>Early Morning</td><td>0.40 (0.51 0.33)</td><td>−5.54 (−9.38–3.03)</td><td>0.65</td><td>0.37</td><td... | <table><tr><td rowspan="3">5/2/2016</td><td>Early Morning</td><td>0.29 (0.33 0.27)</td><td>−5.23 (−6.66–4.05)</td><td>0.53</td><td>0.21</td><td>343</td></tr><tr><td>Landsat Overpass</td><td>0.62 (0.63 0.60)</td><td>−2.21 (−2.49–1.94)</td><td>0.95</td><td>0.46</td><td>299</td></tr><tr><td>Mid Afternoon</td><td>0.65 (0.6... |
8bc66ae2b7089d49a52a34b5bd5fe82939032c3d182332d2540af177a1d525de.png | complex | <table><tr><td rowspan="2">SNP</td><td rowspan="2">Model/Allele</td><td rowspan="2">Genotype</td><td>Control</td><td>ASD</td><td rowspan="2">OR (95% CI)</td><td rowspan="2"><i>p</i></td></tr><tr><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td>rs1801123</td><td>Additive</td><td>AA</td><td>73 (49.7)</td><td>114 (6... | <table><tr><td rowspan="2">SNP</td><td rowspan="2">Model/Allele</td><td rowspan="2">Genotype</td><td>Control</td><td>ASD</td><td rowspan="2">OR (95% CI)</td></tr><tr><td>n (%)</td><td>n (%)</td></tr><tr><td>rs1801123</td><td>Additive</td><td>AA</td><td>73 (49.7)</td><td>114 (63.3)</td><td>1</td></tr><tr><td>Ala804Ala</... | <table><tr><td rowspan="2">p</td></tr><tr></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.022</td></tr><tr><td></td></tr><tr><td>0.013</td></tr><tr><td></td></tr><tr><td>0.48</td></tr><tr><td></td></tr><tr><td>0.022</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.8</td></tr><tr><td></td></tr><tr><td>0.93</td>... |
f82d9779f51d27d3601221b3010f3324b4dbee27ee1195a63f819c8c06930344.png | complex | <table><tr><td colspan="7">Content of Hg<sup>2+</sup> added to various samples (<i>n</i> = 7)</td></tr><tr><td colspan="6">PEI-AuNP probe</td><td>DMA</td></tr><tr><td>Sample</td><td>Added amount (<i>μ</i>M)</td><td>Detected amount (<i>μ</i>M)</td><td>Coefficient of variation (%)</td><td>Recovery (%)</td><td>L... | <table><tr><td colspan="7">Content of Hg2+ added to various samples (n = 7)</td></tr><tr><td colspan="6">PEI-AuNP probe</td><td>DMA</td></tr><tr><td>Sample</td><td>Added amount </td><td>Detected amount (μM)</td><td>Coeffi</td><td>Reco</td><td>LOD (n</td><td>Detected amount </td></tr></table> | <table><tr><td></td><td>(μM)</td><td></td><td>cient of variation (%)</td><td>very (%)</td><td>M)</td><td>(μM)</td></tr><tr><td rowspan="2">Tap water</td><td>0.150</td><td>0.149 ± 1.53 × 10−4</td><td>0.102</td><td>99.9 ± 0.102</td><td rowspan="2">1.72</td><td>0.153</td></tr><tr><td>0.500</td><td>0.499 ± 0.0101</td><td>2... |
a62b09f643871f53831f66ce825f5aacf9c79d8642b87c53e73297e6acdcde36.png | simple | <table><tr><td>Reasons of unwillingness or hesitation</td><td>Will not be vaccinated</td><td>Indecisive</td><td>Total</td></tr><tr><td>Possible side effects</td><td>267 (74.8)</td><td>251 (82.0)</td><td>518 (78.1)</td></tr><tr><td>Lack of comprehensive field evaluation before marketing</td><td>266 (74.5)</td><td>241 (7... | <table><tr><td>Reasons of unwillingness or hesitation</td></tr><tr><td>Possible side effects</td></tr><tr><td>Lack of comprehensive field evaluation before marketing</td></tr><tr><td>Implementation in our country before wide implementation in other countries</td></tr><tr><td>Vaccines which will be administered here are... | <table><tr><td>Will not be vaccinated</td><td>Indecisive</td><td>Total</td></tr><tr><td>267 (74.8)</td><td>251 (82.0)</td><td>518 (78.1)</td></tr><tr><td>266 (74.5)</td><td>241 (78.8)</td><td>507 (76.5)</td></tr><tr><td>199 (55.9)</td><td>184 (60.1)</td><td>383 (57.9)</td></tr><tr><td>153 (42.9)</td><td>137 (44.9)</td>... |
1d8008b17470a6f7dc0bc568951d615eff9b7b88db710caf48c228ff203dcadd.png | complex | <table><tr><td></td><td>Basal</td><td>3 H</td><td>5 H</td><td>24 H</td></tr><tr><td colspan="5">PT, %</td></tr><tr><td>Control</td><td>62.7±7.3</td><td>62.7±3.6</td><td>56.3±3.6</td><td>62.7±3.6</td></tr><tr><td>CM352</td><td>62.7±5.1</td><td>62.0±2.6</td><td>63.7±4.0</td><td>65.1... | <table><tr><td></td><td>Basal</td><td>3 H</td><td>5 H</td><td>24 H</td></tr></table> | <table><tr><td colspan="5">PT, %</td></tr><tr><td>Control</td><td>62.7±7.3</td><td>62.7±3.6</td><td>56.3±3.6</td><td>62.7±3.6</td></tr><tr><td>CM352</td><td>62.7±5.1</td><td>62.0±2.6</td><td>63.7±4.0</td><td>65.1±7.6</td></tr><tr><td colspan="5">aPTT, s</td></tr><tr><td>Control</td><td>19.0±1.0</td><td>19.7±1.5</td><td... |
f682adf54c63f31a7fbecdcc06ea2a27bb55e42fae36cb092c7fc0cbec60f9ce.png | simple | <table><tr><td>Ionphore of mercury(II) electrodes in FIA system</td><td>LR (M)</td><td>DL (M)</td></tr><tr><td>4,7,13,16-tetrathenoyl-1,10-dioxa-4,7,13, 16-tetraazacyclooctadecane [23]</td><td>3.16 × 10<sup>−6</sup>–1 × 10<sup>−3</sup></td><td>3.16 × 10<sup>−6</sup></td></tr><tr><... | <table><tr><td>Ionphore of mercury(II) electrodes in FIA system</td><td>LR (M)</td><td>DL (M)</td></tr><tr><td>4,7,13,16-tetrathenoyl-1,10-dioxa-4,7,13, 16-tetraazacyclooctadecane [23]</td><td>3.16 × 10−6–1 × 10−3</td><td>3.16 × 10−6</td></tr></table> | <table><tr><td>Ionphore of mercury(II) electrodes in FIA system</td><td>LR (M)</td><td>DL (M)</td></tr><tr><td>7,16-dithenyl-l,4,10,13-tetraoxa-7, 16-diazacyclooctadecane [28]</td><td>3.16 × 10−6–1 × 10−3</td><td>3.16 × 10−6</td></tr><tr><td>[This study]</td><td>5 × 10−6–1 × 10−1</td><td>5 × 10−6</td></tr></table> |
36910dcbac8d74bdae9d2bc52436032aa46484cee416a5e8d6b6b7161f96b6e0.png | simple | <table><tr><td></td><td>Magnesium group(<i>n</i> = 30)</td><td>Control group(<i>n</i> = 30)</td><td><i>P</i>-value*</td></tr><tr><td>Age (y)</td><td>25 ± 3</td><td>26 ± 3</td><td>0.41</td></tr><tr><td>Height (cm)</td><td>162 ± 3</td><td>162 ± 3</td><td>0.42</td></tr><tr><td>Weight (kg)</td><td>72 &#... | <table><tr><td></td><td>Magnesium group(n = 30)</td><td>Control group(n = 30)</td><td>P-value*</td></tr><tr><td>Age (y)</td><td>25 ± 3</td><td>26 ± 3</td><td>0.41</td></tr><tr><td>Height (cm)</td><td>162 ± 3</td><td>162 ± 3</td><td>0.42</td></tr></table> | <table><tr><td>Weight (kg)</td><td>72 ± 4</td><td>72 ± 4</td><td>0.84</td></tr><tr><td>Gestational age (week)</td><td>39 ± 1</td><td>39 ± 1</td><td>0.60</td></tr><tr><td>Duration of surgery (min)</td><td>45 ± 7</td><td>47 ± 7</td><td>0.41</td></tr></table> |
a75ec148dcbf023162c6317490184175d24a207e331cd3d41d3889726c9da6dc.png | simple | <table><tr><td>Diagnostic characteristics</td><td>Two parameters</td><td>Three parameters</td><td>Four parameters</td></tr><tr><td>Sensitivity</td><td>96.5%</td><td>89.5%</td><td>63.2%</td></tr><tr><td>Specificity</td><td>66.0%</td><td>87.2%</td><td>95.7%</td></tr><tr><td>Positive predictive value</td><td>77.5%</td><td... | <table><tr><td>Diagnostic characteristics</td><td>Two parameters</td><td>Three parameters</td><td>Four parameters</td></tr><tr><td>Sensitivity</td><td>96.5%</td><td>89.5%</td><td>63.2%</td></tr></table> | <table><tr><td>Diagnostic characteristics</td><td>Two parameters</td><td>Three parameters</td><td>Four parameters</td></tr><tr><td>Specificity</td><td>66.0%</td><td>87.2%</td><td>95.7%</td></tr><tr><td>Positive predictive value</td><td>77.5%</td><td>89.5%</td><td>94.7%</td></tr><tr><td>Negative predictive value</td><td... |
741a3003c5c4725d49b26f8ddba1506e60574bbfe27fa7d40a74acdf5727cbad.png | complex | <table><tr><td><i>Outcome variables</i></td><td><i>Total</i><i>%</i></td><td colspan="2"><i>Gender (%)</i></td><td></td></tr><tr><td><i>n = 775</i></td><td></td><td>Boys(n = 354)</td><td>Girls(n = 421)</td><td></td></tr><tr><td>Physical activity</td><td></td><td></td><td></td><td>***</td></tr><tr><td>≤ 2 hours MV... | <table><tr><td>Outcome variables</td><td>Total%</td><td colspan="2">Gender (%)</td><td></td></tr><tr><td>n = 775</td><td></td><td>Boys(n = 354)</td><td>Girls(n = 421)</td><td></td></tr><tr><td>Physical activity</td><td></td><td></td><td></td><td>***</td></tr><tr><td>≤ 2 hours MVPA/day (low)</td><td>49.4</td><td>37.3</t... | <table><tr><td>Outcome variables</td><td>Total%</td><td colspan="2">Gender (%)</td><td></td></tr><tr><td>n = 775</td><td></td><td>Boys(n = 354)</td><td>Girls(n = 421)</td><td></td></tr><tr><td>≤ 5 portions/day (low)</td><td>47.6</td><td>53.1</td><td>43.0</td><td></td></tr><tr><td>≥ 5 portions/day (high)</td><td>52.4</t... |
bb2042306ade498a4847a192d141d98df441fd4e6942bac760eaefc2da9c27cc.png | complex | <table><tr><td> </td><td colspan="3"><i>Leptin</i></td><td colspan="3"><i>Insulin</i></td></tr><tr><td> </td><td><i>Fat adj. height</i></td><td><i>Height adj. fat</i></td><td><i>Height adj. BMI</i></td><td><i>Fat adj. height</i></td><td><i>Height adj. fat</i></td><td><i>Height adj. BMI</i></td></tr><tr><td colspan="7">... | <table><tr><td></td><td colspan="3">Leptin</td><td colspan="3">Insulin</td></tr></table> | <table><tr><td></td><td>Fat adj. height</td><td>Height adj. fat</td><td>Height adj. BMI</td><td>Fat adj. height</td><td>Height adj. fat</td><td>Height adj. BMI</td></tr><tr><td colspan="7">Boys</td></tr><tr><td colspan="7">Visit</td></tr><tr><td>7</td><td>0.68**</td><td>−0.20**</td><td>0.05</td><td>0.28**</td><td>−0.02... |
d02e05927ed0260e7074e8c4b299379db6239be40d61c601789d4ca49d8989ba.png | complex | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose(p.o.)</td><td colspan="2">Time (sec) spent in</td><td colspan="2">No. of entry in</td><td colspan="2">% of total time (sec) spent in</td><td colspan="2">% of entries in</td></tr><tr><td>Openarm</td><td>Closearm</td><td>Openarm</td><td>Closearm</td><td>Openar... | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose(p.o.)</td><td colspan="2">Time (sec) spent in</td><td colspan="2">No. of entry in</td><td colspan="2">% of total time (sec) spent in</td><td colspan="2">% of entries in</td></tr><tr><td>Openarm</td><td>Closearm</td><td>Openarm</td><td>Closearm</td><td>Openar... | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose(p.o.)</td><td colspan="2">Time (sec) spent in</td><td colspan="2">No. of entry in</td><td colspan="2">% of total time (sec) spent in</td><td colspan="2">% of entries in</td></tr><tr><td>Openarm</td><td>Closearm</td><td>Openarm</td><td>Closearm</td><td>Openar... |
a2dbecb286a5e3cc6520eecd6faaf6745574b89c9d6406628bed2a31dd264164.png | complex | <table><tr><td>Items</td><td>Inpatients</td><td>Outpatients</td><td colspan="3">Cost per patient (€), mean (SD)</td></tr><tr><td></td><td>One-day stay</td><td>One visit</td><td>Inpatients<sup>a</sup></td><td>Outpatients<sup>b</sup></td><td><i>P</i> value</td></tr><tr><td>Staff salary<sup>c</sup></td><td>228.17<su... | <table><tr><td>Items</td><td>Inpatients</td><td>Outpatients</td></tr><tr><td></td><td>One-day stay</td><td>One visit</td></tr><tr><td>Staff salaryc</td><td>228.17d</td><td>80.52</td></tr><tr><td>QDU (1) and (2) visitse</td><td>na</td><td>127.24</td></tr><tr><td>Diagnostic testsf</td><td>83.48</td><td>218.77</td></tr><t... | <table><tr><td colspan="3">Cost per patient (€), mean (SD)</td></tr><tr><td>Inpatientsa</td><td>Outpatientsb</td><td>P value</td></tr><tr><td>2806.49 (174.00)</td><td>262.50 (22.92)</td><td><.001</td></tr><tr><td>na</td><td>414.80 (0.11)</td><td></td></tr><tr><td>1026.80 (76.00)</td><td>713.19 (38.85)</td><td><.001</td... |
782dedd996409febe6c96925f423a15766df1b7449bac34b959ec23b5a5ec4b7.png | simple | <table><tr><td>Haplogroup</td><td>n</td><td>Frequency (%)</td></tr><tr><td>B4*</td><td>4</td><td>1.2</td></tr><tr><td>B4a1*</td><td>18</td><td>5.6</td></tr><tr><td>B4a1a1</td><td>16</td><td>4.9</td></tr><tr><td>B4a1a3a</td><td>5</td><td>1.5</td></tr><tr><td>B4b1</td><td>8</td><td>2.5</td></tr><tr><td>B4c1b2a2</td><td>9... | <table><tr><td>Haplogroup</td><td>n</td><td>Frequency (%)</td></tr><tr><td>B4*</td><td>4</td><td>1.2</td></tr><tr><td>B4a1*</td><td>18</td><td>5.6</td></tr><tr><td>B4a1a1</td><td>16</td><td>4.9</td></tr><tr><td>B4a1a3a</td><td>5</td><td>1.5</td></tr><tr><td>B4b1</td><td>8</td><td>2.5</td></tr><tr><td>B4c1b2a2</td><td>9... | <table><tr><td>R14</td><td>2</td><td>0.6</td></tr><tr><td>Total</td><td>324</td><td>100</td></tr></table> |
80da3b2ab37f3ea3f6232d9824c61d7ab90e450f8deba96723bd7ea60302b7c2.png | simple | <table><tr><td>Characteristics</td><td></td><td>Sweden (%)</td><td>Italy (%)</td><td>p*</td></tr><tr><td>Number of respondents</td><td></td><td>272</td><td>149</td><td></td></tr><tr><td>Gender</td><td>Male</td><td>166 (61.0)</td><td>113 (75.8)</td><td></td></tr><tr><td></td><td>Female</td><td>106 (39.0)</td><td>36 (24.... | <table><tr><td>Characteristics</td><td></td><td>Sweden (%)</td><td>Italy (%)</td><td>p*</td></tr><tr><td>Number of respondents</td><td></td><td>272</td><td>149</td><td></td></tr><tr><td>Gender</td><td>Male</td><td>166 (61.0)</td><td>113 (75.8)</td><td></td></tr><tr><td></td><td>Female</td><td>106 (39.0)</td><td>36 (24.... | <table><tr><td>Characteristics</td><td></td><td>Sweden (%)</td><td>Italy (%)</td><td>p*</td></tr><tr><td></td><td>Missing data</td><td>5</td><td>2</td><td></td></tr><tr><td>Work-related factors</td><td></td><td></td><td></td><td></td></tr><tr><td>Recent degrading experiences/harassment at work</td><td>Yes</td><td>49 (1... |
593fdc0b25a1b98f1062f8b7c75230c4a08df6629d4944fbb0d1e0340390d8de.png | complex | <table><tr><td>Question</td><td>Domain</td><td colspan="2">Unadjusted odds ratios</td><td colspan="2">Adjusted odds ratios on age and sex</td><td colspan="2">Adjusted odds ratios on age, sex and number of years of residence in France</td></tr><tr><td> </td><td> </td><td>Value</td><td>CI</td><td>Value</td><td>CI</td><td... | <table><tr><td>Question</td><td>Domain</td><td colspan="2">Unadjusted odds ratios</td><td>Adjusted odds ratios on age and sex</td></tr><tr><td></td><td></td><td>Value</td><td>CI</td><td>Value</td></tr><tr><td>1*</td><td>I</td><td>1.41</td><td>1.01 1.97</td><td>1.43</td></tr><tr><td>2*</td><td>I</td><td>1.58</td><td>1.1... | <table><tr><td>Adjusted odds ratios on age and sex</td><td colspan="2">Adjusted odds ratios on age, sex and number of years of residence in France</td></tr><tr><td>CI</td><td>Value</td><td>CI</td></tr><tr><td>1.02 2.00</td><td>1.43</td><td>1.02–2.00</td></tr><tr><td>1.17– 2.23</td><td>1.61</td><td>1.17–2.23</td></tr><t... |
db808cd1c458e4f697d65aabfad9b45f70d14ebe8e0e27f7296f79fa04c65e32.png | complex | <table><tr><td>Study population</td><td>Survey no.</td><td>Time of survey</td><td>Survey population</td><td>No. examined (%)</td><td>No. positive for mf (%)</td><td>Mf GMI* for all examined</td><td>Mf GMI* for positives</td></tr><tr><td rowspan="7">Kirare</td><td>1</td><td>Sep-04</td><td>530</td><td>471 (88.9)</td><td>... | <table><tr><td>Study population</td><td>Survey no.</td><td>Time of survey</td><td>Survey population</td><td>No. examined (%)</td><td>No. positive for mf (%)</td><td>Mf GMI* for all examined</td><td>Mf GMI* for positives</td></tr><tr><td rowspan="7">Kirare</td><td>1</td><td>Sep-04</td><td>530</td><td>471 (88.9)</td><td>... | <table><tr><td>Study population</td><td>Survey no.</td><td>Time of survey</td><td>Survey population</td><td>No. examined (%)</td><td>No. positive for mf (%)</td><td>Mf GMI* for all examined</td><td>Mf GMI* for positives</td></tr><tr><td></td><td></td><td>Nov-10</td><td>504</td><td>)#</td><td>§ (4.7)</td><td></td><td>3.... |
c95b6eedb215f7c9f0c5da50f05f51551d2edbd27a065fb18077f7b5e02ae24e.png | complex | <table><tr><td></td><td></td><td colspan="2">Composite SES measure</td><td colspan="2">Adults in poverty measure</td></tr><tr><td></td><td>Individual</td><td>Group</td><td>Multilevel</td><td>Group</td><td>Multilevel</td></tr><tr><td colspan="6">Individual-level education</td></tr><tr><td> Low</td><td>1.00 (reference)</... | <table><tr><td></td><td></td><td colspan="2">Composite SES measure</td><td colspan="2">Adults in poverty measure</td></tr><tr><td></td><td>Individual</td><td>Group</td><td>Multilevel</td><td>Group</td><td>Multilevel</td></tr><tr><td colspan="6">Individual-level education</td></tr><tr><td>Low</td><td>1.00 (reference)</t... | <table><tr><td></td><td></td><td colspan="2">Composite SES measure</td><td colspan="2">Adults in poverty measure</td></tr><tr><td></td><td>Individual</td><td>Group</td><td>Multilevel</td><td>Group</td><td>Multilevel</td></tr><tr><td>dium</td><td>30 (0.82–2.07)</td><td></td><td>32 (0.84–2.06)</td><td></td><td>8)</td></t... |
5e848d206a7032766e8475e807b67fcafc71b11f23759f027cd3b0f8314b3e7a.png | simple | <table><tr><td>Gene</td><td>Gene position (chromosome - bp)*</td><td>SNP location (chromosome - bp)</td><td>NCBI SNP number</td><td>Variation (5’orientation)</td><td>Position in CDS</td><td>Position in protein</td><td>Aminoacid substitution</td></tr><tr><td><i>TEKT4</i></td><td>25: 871,130..877,122</td><td>874,67... | <table><tr><td>Gene</td><td>Gene position (chromosome - bp)*</td><td>SNP location (chromosome - bp)</td><td>NCBI SNP number</td><td>Variation (5’orientation)</td><td>Position in CDS</td><td>Position in protein</td><td>Aminoacid substitution</td></tr><tr><td>TEKT4</td><td>25: 871,130..877,122</td><td>874,677</td><td>rs1... | <table><tr><td>CYLC1</td><td>X:69,903,617..69,933,552</td><td>69,914,225</td><td>rs477320469</td><td>T/A</td><td>818</td><td>273</td><td>Y/F</td></tr><tr><td>UXT</td><td>X:91,468,065..91,474,474</td><td>91,472,521</td><td>rs132821996</td><td>C/T</td><td>344</td><td>115</td><td>S/N</td></tr><tr><td>SPACA5</td><td>X:92,7... |
0173683f20a495c8b8bf089a244d7fa2456b3b5ecb9ec8a6a72e694cfe00d4b5.png | complex | <table><tr><td> </td><td colspan="2">Global</td><td colspan="2">Septal</td><td colspan="2">Regional</td></tr><tr><td> </td><td>MBF</td><td>PN</td><td>MBF</td><td>PN</td><td>MBF</td><td>PN</td></tr><tr><td>Reference method</td><td>1.20 ± 0.44</td><td>0.20 ± 0.08</td><td>1.23 ± 0.56*</td><td>0.28 ± 0.... | <table><tr><td></td><td colspan="2">Global</td><td colspan="2">Septal</td><td colspan="2">Regional</td></tr><tr><td></td><td>MBF</td><td>PN</td><td>MBF</td><td>PN</td><td>MBF</td><td>PN</td></tr></table> | <table><tr><td>Reference method</td><td>1.20 ± 0.44</td><td>0.20 ± 0.08</td><td>1.23 ± 0.56*</td><td>0.28 ± 0.11*</td><td>1.22 ± 0.68</td><td>0.34 ± 0.21</td></tr><tr><td>Accelerated method</td><td>1.24 ± 0.25</td><td>0.08 ± 0.05</td><td>1.28 ± 0.44</td><td>0.17 ± 0.06</td><td>1.28 ± 0.46</td><td>0.21 ± 0.11</td></tr><... |
c908a38802912e22d2c32da26c73b99c40168e2ff1ba4d2b8b6fdef139f3cb86.png | complex | <table><tr><td>Scenario</td><td>Intervention</td><td>Baseline</td><td>2020 coverage targets</td><td>2025 coverage targets</td><td>2030 coverage targets</td></tr><tr><td>1. Sustain</td><td>All</td><td colspan="4">Maintain coverage of all interventions at 2011–2013 levels</td></tr><tr><td>2. Accelerate</td><td>Vect... | <table><tr><td>Scenario</td><td>Intervention</td><td>Baseline</td></tr><tr><td>1. Sustain</td><td>All</td><td>Maintain coverage of all interventions at 2011–2013 levels</td></tr><tr><td>2. Accelerate</td><td>Vector controlLLINIRS</td><td>Means of 2011–2013 country-specific coverage</td></tr><tr><td></td><td>Other measu... | <table><tr><td>2020 coverage targets</td><td>2025 coverage targets</td><td>2030 coverage targets</td></tr><tr><td colspan="3">Maintain coverage of all interventions at 2011–2013 levels</td></tr><tr><td>80% with LLIN replaced every 3 years</td><td>90% with LLIN replaced every 2 years</td><td>Maintain coverage</td></tr><... |
637f39ae0a49de21507a64c2aaea192600b0440bdebbed29c74e4ae84b84f726.png | simple | <table><tr><td>Dataset</td><td># Total genes (<i>T</i>)</td><td># Instances (<i>n</i>)</td><td># Classes (<i>C</i>)</td></tr><tr><td>Colon tumor</td><td>2000</td><td>62</td><td>2</td></tr><tr><td>Central nervous system </td><td>7129</td><td>60</td><td>2</td></tr><tr><td>Leukaemia</td><td>6817</td><td>72</td><td>2</td><... | <table><tr><td>Dataset</td><td># Total genes (T)</td><td># Instances (n)</td><td># Classes (C)</td></tr><tr><td>Colon tumor</td><td>2000</td><td>62</td><td>2</td></tr><tr><td>Central nervous system</td><td>7129</td><td>60</td><td>2</td></tr><tr><td>Leukaemia</td><td>6817</td><td>72</td><td>2</td></tr><tr><td>Breast can... | <table><tr><td>Lung cancer</td><td>12533</td><td>181</td><td>5</td></tr></table> |
40390bec323b878e3877d4bf6808ec8693b4db95ae9a0c1ca8b4a640370e7dc3.png | simple | <table><tr><td> </td><td>Regression coefficient</td><td>S.E</td><td>Odds ratio</td><td>95% C.I</td><td>P value</td></tr><tr><td>Retrovirus status</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>(positive vs negative)</td><td>1.67</td><td>0.70</td><td>5.68</td><td>1.35 - 21.20</td><td>0.02</td></tr><t... | <table><tr><td></td><td>Regression coefficient</td><td>S.E</td></tr><tr><td>Retrovirus status</td><td></td><td></td></tr><tr><td>(positive vs negative)</td><td>1.67</td><td>0.70</td></tr><tr><td>Gender (male vs female)</td><td>0.85</td><td>0.47</td></tr><tr><td>Age (years)</td><td>0.12</td><td>0.05</td></tr><tr><td>Con... | <table><tr><td>Odds ratio</td><td>95% C.I</td><td>P value</td></tr><tr><td></td><td></td><td></td></tr><tr><td>5.68</td><td>1.35 - 21.20</td><td>0.02</td></tr><tr><td>2.30</td><td>0.96 - 6.00</td><td>0.07</td></tr><tr><td>1.10 1</td><td>1.01 - 1.25</td><td>0.02</td></tr><tr><td></td><td></td><td><0.02</td></tr></table> |
888803b6f4d0bbd2fb2337f8f136556a7e2bb85cc4d5792aa9d1708f8a66740d.png | complex | <table><tr><td></td><td>Number</td><td colspan="2">pAkt</td><td><i>P </i>value</td></tr><tr><td></td><td></td><td>Median</td><td>Range</td><td></td></tr><tr><td>Total</td><td>141</td><td>36.0</td><td>0–255.0</td><td></td></tr><tr><td>Ethnicity</td><td></td><td></td><td></td><td></td></tr><tr><td> African-American... | <table><tr><td></td><td>Number</td><td colspan="2">pAkt</td><td>P value</td></tr><tr><td></td><td></td><td>Median</td><td>Range</td><td></td></tr><tr><td>Total</td><td>141</td><td>36.0</td><td>0–255.0</td><td></td></tr><tr><td>Ethnicity</td><td></td><td></td><td></td><td></td></tr><tr><td>African-American</td><td>72</t... | <table><tr><td>Poorly differentiated</td><td>97</td><td>40.8</td><td>0–255.0</td><td>0.094</td></tr><tr><td>ER/PR status</td><td></td><td></td><td></td><td></td></tr><tr><td>ER/PR+</td><td>81</td><td>30.0</td><td>0–255.0</td><td></td></tr><tr><td>ER/PR-</td><td>60</td><td>47.3</td><td>0–170.0</td><td>0.164</td></tr><tr... |
c7199ed308cf028217391a435426a1eaa3a5f4288b63c66b7e47a5f98694bc5b.png | simple | <table><tr><td>Plant</td><td>Tissue</td><td>InsP<sub>6</sub> (μM)</td><td>Ins(1,2,4,5,6)P<sub>5</sub> (μM)</td></tr><tr><td><i>Zea mays</i></td><td>leaves</td><td>101–198 (3)</td><td>nd</td></tr><tr><td><i>Oryza sativa</i></td><td>leaves</td><td>9–49 (6)</td><td>nd</td></tr><tr><td><i>Arabidopsis ... | <table><tr><td>Plant</td><td>Tissue</td><td>InsP6 (μM)</td><td>Ins(1,2,4,5,6)P5 (μM)</td></tr><tr><td>Zea mays</td><td>leaves</td><td>101–198 (3)</td><td>nd</td></tr><tr><td>Oryza sativa</td><td>leaves</td><td>9–49 (6)</td><td>nd</td></tr><tr><td>Arabidopsis thaliana</td><td>leaves</td><td>29–89 (9)</td><td>2–22 (5)</t... | <table><tr><td>Solanum lycopersicum</td><td>leaves</td><td>39–65 (3)</td><td>nd</td></tr><tr><td>Trifolium repens</td><td>leaves</td><td>21 (1)</td><td>6 (1)</td></tr><tr><td>Acer rubrum</td><td>leaves</td><td>35 (1)</td><td>2 (1)</td></tr><tr><td>Ginkgo biloba</td><td>leaves</td><td>61 (1)</td><td>nd</td></tr><tr><td>... |
b13263a3400b158e5e44f54736ac39d811258cefa5b0bc3fbb8d4e6df309c34d.png | simple | <table><tr><td>Gene Symbol</td><td>Gene name</td></tr><tr><td>MBD2</td><td>Methyl-CpG binding domain protein 2</td></tr><tr><td>FMO3</td><td>Flavin containing monooxygenase 3</td></tr><tr><td>RORC</td><td>RAR-related orphan receptor C</td></tr><tr><td>SGCG</td><td>Sarcoglycan, gamma (35kDa dystrophin-associated glycopr... | <table><tr><td>Gene Symbol</td><td>Gene name</td></tr><tr><td>MBD2</td><td>Methyl-CpG binding domain protein 2</td></tr><tr><td>FMO3</td><td>Flavin containing monooxygenase 3</td></tr><tr><td>RORC</td><td>RAR-related orphan receptor C</td></tr><tr><td>SGCG</td><td>Sarcoglycan, gamma (35kDa dystrophin-associated glycopr... | <table><tr><td>PFKM</td><td>Phosphofructokinase, muscle</td></tr><tr><td>MOCS1</td><td>Molybdenum cofactor synthesis 1</td></tr><tr><td>TRA2A</td><td>Transformer 2 alpha homolog</td></tr></table> |
bb0aaf026d772141d33e005f5cb31d531cb0c777c8e8717e42f65132a0a69ee8.png | complex | <table><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2">Genetic effect</td><td colspan="2">Genotype-by-age effect</td><td colspan="2">Genetic + genotype-by-age effects</td></tr><tr><td>SNP<sup>a</sup></td><td>Chr<sup>b</sup></td><td>Position</td><td>Alleles</td><td>MAF</td><td>LRT1</td><td>-log(<i>p</i>... | <table><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2">Genetic effect</td><td colspan="2">Genotype-by-age effect</td><td colspan="2">Genetic + genotype-by-age effects</td></tr><tr><td>SNPa</td><td>Chrb</td><td>Position</td><td>Alleles</td><td>MAF</td><td>LRT1</td><td>-log(p)</td><td>LRT2</td><td>-log(p... | <table><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2">Genetic effect</td><td colspan="2">Genotype-by-age effect</td><td colspan="2">Genetic + genotype-by-age effects</td></tr><tr><td>SNPa</td><td>Chrb</td><td>Position</td><td>Alleles</td><td>MAF</td><td>LRT1</td><td>-log(p)</td><td>LRT2</td><td>-log(p... |
b0d64d606f4e6ad13f925d01b6f2434b912cbf33c6a9a6e0baafb5e459dbd968.png | complex | <table><tr><td rowspan="2">Variable</td><td> </td><td>Normal (<i>n</i> = 2,537)</td><td> </td><td>VSD (<i>n</i> = 124)</td><td rowspan="2"><i>P </i>value</td></tr><tr><td>Mean ± SD</td><td>10 to 90%</td><td>Mean ± SD</td><td>10 to 90%</td></tr><tr><td>NBL (mm)</td><td>6.74 ± 0.87</td><td>5.60 to 7.90</td... | <table><tr><td rowspan="2">Variable</td><td></td><td>Normal (n = 2,537)</td><td></td><td>VSD (n = 124)</td><td rowspan="2">P value</td></tr><tr><td>Mean ± SD</td><td>10 to 90%</td><td>Mean ± SD</td><td>10 to 90%</td></tr><tr><td>NBL (mm)</td><td>6.74 ± 0.87</td><td>5.60 to 7.90</td><td>6.40 ± 0.79</td><td>5.30 to 7.40<... | <table><tr><td>HC (mm)</td><td>197.34 ± 15.57</td><td>177.00 to 218.00</td><td>193.94 ± 14.66</td><td>175.00 to 213.40</td><td>0.017</td></tr><tr><td>AC (mm)</td><td>177.08 ± 16.15</td><td>156.00 to 198.00</td><td>171.36 ± 16.12</td><td>150.82 to 194.45</td><td><0.0001</td></tr><tr><td>Femur length (mm)</td><td>37.33 ±... |
bc5153abdc510450944f4d5ef9b7aaa9e8e501ee51d2aadb25746af095c0f303.png | simple | <table><tr><td>Variables</td><td>Cases(n=73)</td><td>Controls(n=146)</td></tr><tr><td>Having ANC visit</td><td></td><td></td></tr><tr><td> Yes</td><td>56(76.7%)</td><td>121(82.9%)</td></tr><tr><td> No</td><td>17(23.3%)</td><td>25(17.1%)</td></tr><tr><td>Gestational Age at first ANC</td><td></td><td></td></tr><tr><td> F... | <table><tr><td>Variables</td><td>Cases(n=73)</td><td>Controls(n=146)</td></tr><tr><td>Having ANC visit</td><td></td><td></td></tr><tr><td>Yes</td><td>56(76.7%)</td><td>121(82.9%)</td></tr><tr><td>No</td><td>17(23.3%)</td><td>25(17.1%)</td></tr><tr><td>Gestational Age at first ANC</td><td></td><td></td></tr><tr><td>Firs... | <table><tr><td>> 2 hours</td><td>7(9.6%)</td><td>4(2.7%)</td></tr><tr><td>Place of delivery</td><td></td><td></td></tr><tr><td>Home</td><td>56(76.7%)</td><td>136(93.2%)</td></tr><tr><td>Health Facility</td><td>17(23.3%)</td><td>10(6.8%)</td></tr></table> |
4112c6adc673e9766fde86c55b0e5b32ee11b307dfa25a8c31e37f984c7a6b2f.png | simple | <table><tr><td>First author</td><td>Year</td><td>Country</td><td>Patient (M/F)</td><td>Age (year)</td><td>Technology</td><td>Lgr5 positive threshold</td><td>HR (95 % CI) of OS</td><td>HR (95 % CI) of DFS</td><td>Quality score</td></tr><tr><td>Liu</td><td>2014</td><td>China</td><td>363 (200/166)</td><td>59mean</td><td>I... | <table><tr><td>First author</td><td>Year</td></tr><tr><td>Liu</td><td>2014</td></tr><tr><td>He</td><td>2014</td></tr><tr><td>Gao</td><td>2014</td></tr><tr><td>Wu</td><td>2012</td></tr><tr><td>Hsu</td><td>2013</td></tr><tr><td>Saiqusa</td><td>2012</td></tr><tr><td>Ziskin</td><td>2012</td></tr><tr><td>Valladares-Ayerbes<... | <table><tr><td>Country</td><td>Patient (M/F)</td><td>Age (year)</td><td>Technology</td><td>Lgr5 positive threshold</td><td>HR (95 % CI) of OS</td><td>HR (95 % CI) of DFS</td><td>Quality score</td></tr><tr><td>China</td><td>363 (200/166)</td><td>59mean</td><td>IHC</td><td>NA</td><td>2.604 (1.894–3.584)</td><td>NA</td><t... |
33fed5e5299823482179d871a44f2a8af609df44820ffa57d8d113cee317e29f.png | simple | <table><tr><td>Probe set</td><td>Gene symbol</td><td>Locus</td><td>Description</td><td>Fold difference</td><td>q-value</td></tr><tr><td>209735_at</td><td>ABCG2</td><td>4q22</td><td>ATP-binding cassette, sub-family G (WHITE), member 2</td><td>−1.29</td><td>0.031</td></tr><tr><td>208868_s_at</td><td>GABARAPL1</td><... | <table><tr><td>Probe set</td><td>Gene symbol</td><td>Locus</td><td>Description</td><td>Fold difference</td><td>q-value</td></tr><tr><td>209735_at</td><td>ABCG2</td><td>4q22</td><td>ATP-binding cassette, sub-family G (WHITE), member 2</td><td>−1.29</td><td>0.031</td></tr><tr><td>208868_s_at</td><td>GABARAPL1</td><td>12p... | <table><tr><td>Probe set</td><td>Gene symbol</td><td>Locus</td><td>Description</td><td>Fold difference</td><td>q-value</td></tr><tr><td>221315_s_at</td><td>FGF22</td><td>19p13.3</td><td>fibroblast growth factor 22</td><td>−1.08</td><td>0.042</td></tr><tr><td>221706_s_at</td><td>USE1</td><td>19p13.11</td><td>unconventio... |
6c8f20f15bdf1a48489ab8b2d4a29238b7ef36bf46958261325cec1c74be3d5f.png | complex | <table><tr><td colspan="2">Characteristics</td><td>Hospitalized</td><td>%</td><td>Non-Hospitalized</td><td>%</td></tr><tr><td> </td><td> </td><td>N=8681</td><td> </td><td>N=8681</td><td> </td></tr><tr><td colspan="2">Sex</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>Male</td><td>3588</td><td>41.3</... | <table><tr><td colspan="2">Characteristics</td><td>Hospitalized</td><td>%</td><td>Non-Hospitalized</td><td>%</td></tr><tr><td></td><td></td><td>N=8681</td><td></td><td>N=8681</td><td></td></tr><tr><td colspan="2">Sex</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Male</td><td>3588</td><td>41.3</td><td>35... | <table><tr><td></td><td>CDS score 3-4</td><td>1</td><td></td><td>15</td><td></td></tr><tr><td></td><td>CDS score ≥5</td><td>1948</td><td>22.4</td><td>773</td><td>8.9</td></tr><tr><td colspan="6">Duration of hospitalization</td></tr><tr><td></td><td>1 day</td><td>417</td><td>4.8</td><td></td><td></td></tr><tr><td></td><... |
a2dcad5991a0f4253c7d85e2cd8cca5443b5a6036c1728d70b0a0729f85a08ad.png | simple | <table><tr><td> </td><td>No antibody</td><td>Erbitux ® (anti-ErB1)</td><td>Herceptin ® (anti-ErB2)</td></tr><tr><td>U87Ctrl</td><td>130.1±4.4</td><td>98.3±8.6(*)</td><td>125.6±7.9 (ns)</td></tr><tr><td>U87dn</td><td>144.3±3.3</td><td>104.3±3.9(*)</td><td>131.6±8.8 (ns)</td></tr><... | <table><tr><td></td><td>No antibody</td><td>Erbitux ® (anti-ErB1)</td><td>Herceptin ® (anti-ErB2)</td></tr><tr><td>U87Ctrl</td><td>130.1±4.4</td><td>98.3±8.6(*)</td><td>125.6±7.9 (ns)</td></tr></table> | <table><tr><td>U87dn</td><td>144.3±3.3</td><td>104.3±3.9(*)</td><td>131.6±8.8 (ns)</td></tr></table> |
2f91af3f8f518a46ba2bcb0746d5d2ec3b0b726c71e783f7a7237d8adc3993ba.png | complex | <table><tr><td></td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td><td>(6)</td></tr><tr><td>Outcome variable:</td><td colspan="3">Distance (km) from nearest clinic</td><td colspan="3">At least 2 km from nearest clinic</td></tr><tr><td>Black African</td><td>0.735**</td><td>−0.180</td><td>−0.185<... | <table><tr><td></td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td></tr><tr><td>Outcome variable:</td><td colspan="3">Distance (km) from nearest clinic</td><td>At least 2 km from nearest clinic</td></tr><tr><td>Black African</td><td>0.735**</td><td>−0.180</td><td>−0.185</td><td>0.041</td></tr><tr><td></td><td>(0.310)<... | <table><tr><td>(5)</td><td>(6)</td></tr><tr><td colspan="2">At least 2 km from nearest clinic</td></tr><tr><td>−0.108</td><td>−0.115</td></tr><tr><td>(0.072)</td><td>(0.074)</td></tr><tr><td>−0.284***</td><td>−0.292***</td></tr><tr><td>(0.072)</td><td>(0.073)</td></tr><tr><td>−0.026***</td><td>−0.024***</td></tr><tr><t... |
5668b2bd6d00c5e2bd24372f31abc031edfd504f0cebcf0ddbeaf14520eb4a3b.png | complex | <table><tr><td rowspan="2">Purchase status</td><td colspan="2">Condition</td></tr><tr><td>Loss</td><td>Near-miss</td></tr><tr><td>Non-purchasers</td><td>20.18 (20.41)</td><td>34.74 (25.15)</td></tr><tr><td>Purchasers</td><td>19.43 (9.64)</td><td>61.00 (17.94)*</td></tr></table> | <table><tr><td>Purchase s</td><td colspan="2">C</td></tr></table> | <table><tr><td rowspan="2">tatus</td><td colspan="2">ondition</td></tr><tr><td>Loss</td><td>Near-miss</td></tr><tr><td>Non-purchasers</td><td>20.18 (20.41)</td><td>34.74 (25.15)</td></tr><tr><td>Purchasers</td><td>19.43 (9.64)</td><td>61.00 (17.94)*</td></tr></table> |
5d45e25b0a011765a8262021f6ab1c9ab56345c73b82a6e9daa213149f75fcee.png | complex | <table><tr><td colspan="2"></td><td>HSFD</td><td>HUFD</td><td>HDSD</td><td>HRSD</td></tr><tr><td colspan="2"></td><td>g/Kg</td><td>g/Kg</td><td>g/Kg</td><td>g/Kg</td></tr><tr><td colspan="2">Protein</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Casein</td><td>254.1</td><td>254.1</td><td>212.9</td><td>21... | <table><tr><td colspan="2"></td><td>HSFD</td><td>HUFD</td><td>HDSD</td><td>HRSD</td></tr><tr><td colspan="2"></td><td>g/Kg</td><td>g/Kg</td><td>g/Kg</td><td>g/Kg</td></tr><tr><td colspan="2">Protein</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Casein</td><td>254.1</td><td>254.1</td><td>212.9</td><td>21... | <table><tr><td></td><td>Lard</td><td>364.5</td><td></td><td></td><td></td></tr><tr><td colspan="2">Carbohydrates</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Corn starch</td><td>305</td><td>305</td><td>675</td><td></td></tr><tr><td></td><td>Banana starch</td><td></td><td></td><td></td><td>675</td></tr>... |
6af0f70ec607a87d6f7521fc8d1de9e62f8974fc89396cdb1e6abb707a20460f.png | complex | <table><tr><td>Normal endothelial cells</td><td>Vasculogenic mimicry cells</td></tr><tr><td colspan="2">Similarities</td></tr><tr><td colspan="2">VE-cadherin positive</td></tr><tr><td colspan="2">E-selectin positive</td></tr><tr><td colspan="2">CD34 positive</td></tr><tr><td colspan="2">Differences</td></tr><tr><td>TIE... | <table><tr><td>Normal endothelial cells</td><td>Vasculogenic mimicry cells</td></tr><tr><td colspan="2">Similarities</td></tr><tr><td colspan="2">VE-cadherin positive</td></tr><tr><td colspan="2">E-selectin positive</td></tr><tr><td colspan="2">CD34 positive</td></tr><tr><td colspan="2">Differences</td></tr><tr><td>TIE... | <table><tr><td>Normal endothelial cells</td><td>Vasculogenic mimicry cells</td></tr><tr><td>TIE-1 negative</td><td>TIE-1 positive</td></tr><tr><td>VEGF-C negative</td><td>VEGF-C positive</td></tr><tr><td>Neuropilin 1 negative</td><td>Neuropilin 1 positive</td></tr><tr><td>Endoglin negative</td><td>Endoglin positive</td... |
77e3b4036f3f6da45e7f562ef33f1ff74cf1a21a3f63603f6e1143653a146e3a.png | simple | <table><tr><td>Agent</td><td>Normal dose</td><td>Estimated GFR (creatinine clearance: CrCl)</td></tr><tr><td>Zidovudine</td><td>300 mg twice a day orally</td><td>100 mg thrice a day orally</td></tr><tr><td>Lamivudine</td><td>150 mg twice a day orally</td><td>30–49 mL/min = 150 mg once a day orally15–29 mL/m... | <table><tr><td>Agent</td><td>Normal dose</td><td>Estimated GFR (creatinine clearance: CrCl)</td></tr><tr><td>Zidovudine</td><td>300 mg twice a day orally</td><td>100 mg thrice a day orally</td></tr><tr><td>Lamivudine</td><td>150 mg twice a day orally</td><td>30–49 mL/min = 150 mg once a day orally15–29 mL/min = 100 mg ... | <table><tr><td>Stavudine</td><td>30 mg twice a day orally</td><td>26–50 mL/min = 15 mg twice a day orally<26 mL/min = 15 mg once a day orally</td></tr><tr><td>Didanosine</td><td>>60 kg: 200 mg twice a day orally <60 kg, 125 mg twice a day orally</td><td>30–59 mL/min = 200 mg once a day orally10–29 mL/min = 150 mg once ... |
641fa993ad75ad731c3915550288023267958aed98800a6f3a2d7110afba4ce6.png | simple | <table><tr><td>ASIC channel type</td><td>pH sensitivity (pH<sub>50</sub>) [21]</td><td>Predominant localization</td><td>Likely cellular localization</td><td>Potential function</td><td>References</td></tr><tr><td>ASIC1A</td><td>5.8–6.8</td><td>Central and peripheral nervous systems</td><td>Axons, cell bodies, dend... | <table><tr><td>ASIC channel type</td><td>pH sensitivity (pH50) [21]</td><td>Predominant localization</td><td>Likely cellular localization</td><td>Potential function</td><td>References</td></tr><tr><td>ASIC1A</td><td>5.8–6.8</td><td>Central and peripheral nervous systems</td><td>Axons, cell bodies, dendrites</td><td>Cel... | <table><tr><td>ASIC channel type</td><td>pH sensitivity (pH50) [21]</td><td>Predominant localization</td><td>Likely cellular localization</td><td>Potential function</td><td>References</td></tr><tr><td>ASIC1B</td><td>6.1–6.2</td><td>Peripheral nervous system</td><td>Axons, cell bodies</td><td></td><td>[21, 36]</td></tr>... |
1393b2f5151b50bdceda7aa7cdb4d698624f35d717106ae3e2b048bf3469d6b3.png | complex | <table><tr><td> </td><td>Total female participants n(%)</td><td>Female with DNA methylation data, n(%)</td><td><i>P </i>value</td></tr><tr><td>Factors</td><td>n = 750</td><td>n = 245</td><td> </td></tr><tr><td colspan="4">Maternal history of asthma</td></tr><tr><td>Yes</td><td>80 (10.8)</td><td>30 (12.3)</td><td>0.50</... | <table><tr><td></td><td>Total female participants n(%)</td><td>Female with DNA methylation data, n(%)</td><td>P value</td></tr><tr><td>Factors</td><td>n = 750</td><td>n = 245</td><td></td></tr><tr><td colspan="4">Maternal history of asthma</td></tr><tr><td>Yes</td><td>80 (10.8)</td><td>30 (12.3)</td><td>0.50</td></tr><... | <table><tr><td>Underweight (<18.5)</td><td>10 (1.7)</td><td>4 (2.2)</td><td>0.82</td></tr><tr><td>Normal (18.5- <25)</td><td>355 (61.5)</td><td>109 (59.2)</td><td></td></tr><tr><td>Overweight (≥25.00)</td><td>212 (36.7)</td><td>71 (38.6)</td><td></td></tr><tr><td>Missing</td><td>173</td><td>61</td><td></td></tr><tr><td... |
9367c6298eb1c813621f411915f88b83c820717527951ea665f163fedc4e5009.png | complex | <table><tr><td>Patient No.</td><td>Age</td><td>Gender</td><td>FEV<sub>1</sub> (% pred.)</td><td>COPD</td><td colspan="2">DP (cmH<sub>2</sub>O)</td><td colspan="2">PIF (L/min)</td><td colspan="2">IV (L)</td><td colspan="2">IT (s)</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>GD</td><td>TD</td><td>GD</td>... | <table><tr><td>Patient No.</td><td>Age</td><td>Gender</td><td>FEV1 (% pred.)</td><td>COPD</td><td colspan="2">DP (cmH2O)</td><td colspan="2">PIF (L/min)</td><td colspan="2">IV (L)</td><td colspan="2">IT (s)</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>GD</td><td>TD</td><td>GD</td><td>TD</td><td>GD</td>... | <table><tr><td>4</td><td>70</td><td>Female</td><td>74</td><td>Mod.</td><td>9</td><td>15</td><td>48</td><td>24</td><td>1.7</td><td>1.4</td><td>3.2</td><td>5.0</td></tr><tr><td>5</td><td>52</td><td>Female</td><td>68</td><td>Mod.</td><td>37</td><td>44</td><td>99</td><td>41</td><td>2.0</td><td>1.8</td><td>1.7</td><td>3.8</... |
7f86582189207386cbc5f620172dae13cf91e9bae6c2cb4091dedc68ed62d9ed.png | simple | <table><tr><td>Component </td><td>Slices </td><td>LUTs </td><td>FFs </td><td>Freq.</td></tr><tr><td> Network stack </td><td>1788 </td><td> 1380 </td><td> 2790 </td><td>127.6 MHz </td></tr><tr><td> Adapters </td><td> 624</td><td> 643 </td><td> 981 </td><td> 186.4 MHz </td></tr><tr><td> Bus </td><td> 284 </td><td>210 </t... | <table><tr><td>Component</td><td>Slices</td><td>LUTs</td><td>FFs</td><td>Freq.</td></tr><tr><td>Network stack</td><td>1788</td><td>1380</td><td>2790</td><td>127.6 MHz</td></tr><tr><td>Adapters</td><td>624</td><td>643</td><td>981</td><td>186.4 MHz</td></tr></table> | <table><tr><td>Component</td><td>Slices</td><td>LUTs</td><td>FFs</td><td>Freq.</td></tr><tr><td>Bus</td><td>284</td><td>210</td><td>335</td><td>220 MHz</td></tr></table> |
afc2be7935ad310696205dcac2ed8fdda4a886c73822ac5f86f941c29ee75e8f.png | simple | <table><tr><td>Gene name</td><td>Protein description</td><td>Cellular component</td><td>Biological process</td><td>Predominant normal tissue expression</td><td>Spectral counts</td><td>Position in B596 NAS fraction (sorted by spectral counts)</td></tr><tr><td>CCDC86</td><td>Cytokine-induced protein with coiled-coil doma... | <table><tr><td>Gene name</td><td>Protein description</td><td>Cellular component</td><td>Biological process</td><td>Predominant normal tissue expression</td><td>Spectral counts</td><td>Position in B596 NAS fraction (sorted by spectral counts)</td></tr></table> | <table><tr><td>CCDC86</td><td>Cytokine-induced protein with coiled-coil domain</td><td>Nucleus</td><td>Unknown</td><td>Testis</td><td>106</td><td>22/236</td></tr><tr><td>H2AFY</td><td>Core histone macro-H2A.1</td><td>Nucleus</td><td>Chromatine Structure</td><td>Lung</td><td>42</td><td>44/236</td></tr><tr><td>MECP2</td>... |
78cda7c6eb6f93bcdef8e2cc4cd4cd16d0dc2af3a1f8fdb241d7867b2126ef19.png | simple | <table><tr><td>Sequence</td><td>Length (aa)</td><td>Position(s) in HXB2 (aa)</td><td>Positions in HIVconsv (aa)</td><td>Presence of exact match in LANL-HSD</td><td>NetMHC binding affinity (nM)</td><td>HLA allele</td><td>PEAKS score (−10logP)</td><td>Sample collection time(s) (h)</td></tr><tr><td>YKRWIILGLNK</td><... | <table><tr><td>Sequence</td><td>Length (aa)</td><td>Position(s) in HXB2 (aa)</td><td>Positions in HIVconsv (aa)</td><td>Presence of exact match in LANL-HSD</td><td>NetMHC binding affinity (nM)</td><td>HLA allele</td><td>PEAKS score (−10logP)</td><td>Sample collection time(s) (h)</td></tr><tr><td>YKRWIILGLNK</td><td>11<... | <table><tr><td>PIETVPVKL</td><td>13</td><td>7</td><td>194–206</td><td>No</td><td>)</td><td>2</td><td>52</td><td>, 6</td></tr><tr><td>SPIETVPVKL</td><td>10</td><td>Pol 158–167</td><td>197–206</td><td>Yes</td><td>191 (WB)</td><td>B*07:02</td><td>41.33</td><td>2.5, 3.5, 6</td></tr><tr><td>AIFQSSMTK</td><td>9</td><td>Pol 3... |
4b453830e6aac92d62808d40c5f0fe60785d3ddb46616ec34f6e079c736291ee.png | simple | <table><tr><td>No. of embryos (repeat)</td><td>Cleavage (%)</td><td>Blastocyst (%)</td><td>No. of cells in blastocysts</td></tr><tr><td>1356 (6)</td><td>846 (76.3 ± 4.0)</td><td>367 (26.7 ± 3.9)</td><td>54.6 ± 13.6</td></tr></table> | <table><tr><td>No. of embryos (repeat)</td><td>Cleavage (%)</td><td>Blastocyst (%)</td><td>No. of cells in blastocysts</td></tr></table> | <table><tr><td>1356 (6)</td><td>846 (76.3 ± 4.0)</td><td>367 (26.7 ± 3.9)</td><td>54.6 ± 13.6</td></tr></table> |
baa84bad908220c86674711b5651f65231bf81c0d5e96f5381c71f690706f21f.png | simple | <table><tr><td></td><td></td><td>RHY+ORD+</td><td>RHY−ORD+</td><td>RHY+ORD-</td><td>RHY−ORD−</td></tr><tr><td>Region 1</td><td>GD</td><td>365 (8.38)</td><td>304 (7.19)</td><td>391 (8.69)</td><td>410 (9.41)</td></tr><tr><td></td><td>RPD</td><td>412 (9.20)</td><td>333 (7.90)</td><td>462 (10.18)</td><td>... | <table><tr><td></td><td></td><td>RHY+ORD+</td><td>RHY−ORD+</td><td>RHY+ORD-</td><td>RHY−ORD−</td></tr><tr><td>Region 1</td><td>GD</td><td>365 (8.38)</td><td>304 (7.19)</td><td>391 (8.69)</td><td>410 (9.41)</td></tr><tr><td></td><td>RPD</td><td>412 (9.20)</td><td>333 (7.90)</td><td>462 (10.18)</td><td>448 (10.35)</td></... | <table><tr><td></td><td>REG</td><td>0.10 (0.01)</td><td>0.18 (0.02)</td><td>0.11 (0.01)</td><td>0.24 (0.02)</td></tr><tr><td>Region 4</td><td>GD</td><td>396 (9.43)</td><td>403 (11.07)</td><td>400 (10.32)</td><td>401 (10.57)</td></tr><tr><td></td><td>RPD</td><td>537 (20.22)</td><td>581 (22.34)</td><td>574 (20.99)</td><t... |
0653f96496c5124b6c6d6c930f30c79b33cdd9ed1840e2fe2f57875d43527ac5.png | complex | <table><tr><td></td><td></td><td></td><td colspan="3">Males</td><td colspan="3">Females</td></tr><tr><td></td><td></td><td></td><td>Adjusted Odds Ratio(95%CI): reference time, 1995</td><td></td><td><sup>§</sup>MH χ<sup>2 </sup>for Linear trend, 1995–2003:</td><td>Adjusted Odds Ratio(95%CI): reference ti... | <table><tr><td></td><td></td><td></td><td colspan="3">Males</td><td colspan="3">Females</td></tr><tr><td></td><td></td><td></td><td>Adjusted Odds Ratio(95%CI): reference time, 1995</td><td></td><td>§MH χ2 for Linear trend, 1995–2003:</td><td>Adjusted Odds Ratio(95%CI): reference time, 1995</td><td></td><td>§MH χ2 for L... | <table><tr><td></td><td></td><td></td><td colspan="3">Males</td><td colspan="3">Females</td></tr><tr><td></td><td></td><td></td><td>Adjusted Odds Ratio(95%CI): reference time, 1995</td><td></td><td>§MH χ2 for Linear trend, 1995–2003:</td><td>Adjusted Odds Ratio(95%CI): reference time, 1995</td><td></td><td>§MH χ2 for L... |
b3ca8bf8439908eae2c8a8ec533babdaa6893de502c8bb642a22f194acd3ede4.png | simple | <table><tr><td>Serum biochemical factors</td><td>Malignant cholestasis</td><td>Stone induced cholestasis</td><td>P value</td></tr><tr><td>AST(IU/L)</td><td>87.00±23.06</td><td>167.67±36.15</td><td>0.169</td></tr><tr><td>ALT(IU/L)</td><td>91.87±32.23</td><td>242.00±46.01</td><td>0.050</td></tr><tr><t... | <table><tr><td>Serum biochemical factors</td><td>Malignant cholestasis</td><td>Stone induced cholestasis</td><td>P value</td></tr></table> | <table><tr><td>AST(IU/L)</td><td>87.00±23.06</td><td>167.67±36.15</td><td>0.169</td></tr><tr><td>ALT(IU/L)</td><td>91.87±32.23</td><td>242.00±46.01</td><td>0.050</td></tr><tr><td>AlkPhos (IU/L)</td><td>1269.88±335.91</td><td>852.50±204.53</td><td>0.282</td></tr><tr><td>T Bili (mg/dl)</td><td>11.60±2.72</td><td>5.47±1.6... |
1462213a2ffc64d56c60f41005c89f54a4bf9f5e852fcf06e0650d3e63afd851.png | simple | <table><tr><td>Cycle Rate(Hz)</td><td>AveragePhase 0%Displacement(mm)</td><td>SD ofPhase 0%Displacement(mm)</td><td>AveragePhase 50%Displacement(mm)</td><td>SD ofPhase 50%Displacement(mm)</td></tr><tr><td>0.2</td><td>20.01</td><td>0.04</td><td>−19.65</td><td>0.08</td></tr><tr><td>0.33</td><td>19.96</td><td>0.05</... | <table><tr><td>Cycle Rate(Hz)</td><td>AveragePhase 0%Displacement(mm)</td><td>SD ofPhase 0%Displacement(mm)</td><td>AveragePhase 50%Displacement(mm)</td><td>SD ofPhase 50%Displacement(mm)</td></tr><tr><td>0.2</td><td>20.01</td><td>0.04</td><td>−19.65</td><td>0.08</td></tr></table> | <table><tr><td>0.33</td><td>19.96</td><td>0.05</td><td>−19.64</td><td>0.11</td></tr><tr><td>1</td><td>20.73</td><td>.08</td><td>−18.87</td><td>0.59</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.